US20200010791A9 - Cellular Poration Using Laser Radiation - Google Patents
Cellular Poration Using Laser Radiation Download PDFInfo
- Publication number
- US20200010791A9 US20200010791A9 US16/250,714 US201916250714A US2020010791A9 US 20200010791 A9 US20200010791 A9 US 20200010791A9 US 201916250714 A US201916250714 A US 201916250714A US 2020010791 A9 US2020010791 A9 US 2020010791A9
- Authority
- US
- United States
- Prior art keywords
- cells
- range
- laser
- cargo
- projections
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000005855 radiation Effects 0.000 title claims abstract description 34
- 230000001413 cellular effect Effects 0.000 title description 2
- 239000000758 substrate Substances 0.000 claims abstract description 145
- 238000000034 method Methods 0.000 claims abstract description 63
- 238000012545 processing Methods 0.000 claims abstract description 31
- 239000011248 coating agent Substances 0.000 claims abstract description 10
- 238000000576 coating method Methods 0.000 claims abstract description 10
- 230000001678 irradiating effect Effects 0.000 claims abstract description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 102000004169 proteins and genes Human genes 0.000 claims description 13
- 229920000642 polymer Polymers 0.000 claims description 12
- 230000008859 change Effects 0.000 claims description 11
- 239000012528 membrane Substances 0.000 claims description 7
- 108020004414 DNA Proteins 0.000 claims description 6
- 230000002068 genetic effect Effects 0.000 claims description 6
- 229920002477 rna polymer Polymers 0.000 claims description 6
- 230000001052 transient effect Effects 0.000 claims description 6
- 102000053602 DNA Human genes 0.000 claims description 5
- 239000002105 nanoparticle Substances 0.000 claims description 5
- 230000035699 permeability Effects 0.000 claims description 4
- 239000013612 plasmid Substances 0.000 claims description 4
- 150000007523 nucleic acids Chemical group 0.000 claims description 2
- 239000002096 quantum dot Substances 0.000 claims description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 241
- 229920002307 Dextran Polymers 0.000 description 52
- 239000000523 sample Substances 0.000 description 52
- 238000000684 flow cytometry Methods 0.000 description 48
- 238000010586 diagram Methods 0.000 description 37
- 230000035899 viability Effects 0.000 description 37
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 36
- 230000006870 function Effects 0.000 description 35
- 229910052737 gold Inorganic materials 0.000 description 33
- 239000010931 gold Substances 0.000 description 33
- 239000010410 layer Substances 0.000 description 26
- 238000002474 experimental method Methods 0.000 description 24
- DEGAKNSWVGKMLS-UHFFFAOYSA-N calcein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(O)=O)CC(O)=O)=C(O)C=C1OC1=C2C=C(CN(CC(O)=O)CC(=O)O)C(O)=C1 DEGAKNSWVGKMLS-UHFFFAOYSA-N 0.000 description 19
- 229960002378 oftasceine Drugs 0.000 description 19
- 230000003834 intracellular effect Effects 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000005286 illumination Methods 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 229910052751 metal Inorganic materials 0.000 description 12
- 239000002184 metal Substances 0.000 description 12
- 238000004626 scanning electron microscopy Methods 0.000 description 12
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 11
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 10
- 239000000975 dye Substances 0.000 description 10
- -1 mercapto-ester Polymers 0.000 description 9
- 229910052710 silicon Inorganic materials 0.000 description 9
- 239000010703 silicon Substances 0.000 description 9
- 238000004088 simulation Methods 0.000 description 9
- 235000012431 wafers Nutrition 0.000 description 9
- 230000003833 cell viability Effects 0.000 description 8
- 239000011651 chromium Substances 0.000 description 7
- 239000004205 dimethyl polysiloxane Substances 0.000 description 7
- 238000001095 inductively coupled plasma mass spectrometry Methods 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000012496 blank sample Substances 0.000 description 5
- 239000013068 control sample Substances 0.000 description 5
- 230000005284 excitation Effects 0.000 description 5
- 238000000799 fluorescence microscopy Methods 0.000 description 5
- 239000001046 green dye Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000001878 scanning electron micrograph Methods 0.000 description 5
- 230000002123 temporal effect Effects 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 4
- 229910052804 chromium Inorganic materials 0.000 description 4
- 210000000805 cytoplasm Anatomy 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000000130 stem cell Anatomy 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 3
- 229940119743 dextran 70 Drugs 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000013580 millipore water Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 229920002120 photoresistant polymer Polymers 0.000 description 3
- 239000013047 polymeric layer Substances 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- 108091033409 CRISPR Proteins 0.000 description 2
- 241000272194 Ciconiiformes Species 0.000 description 2
- 108020005004 Guide RNA Proteins 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 101710149632 Pectinesterase A Proteins 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- NRTOMJZYCJJWKI-UHFFFAOYSA-N Titanium nitride Chemical compound [Ti]#N NRTOMJZYCJJWKI-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000003124 biologic agent Substances 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 238000004624 confocal microscopy Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000002716 delivery method Methods 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012799 electrically-conductive coating Substances 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 229920006335 epoxy glue Polymers 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 230000007688 immunotoxicity Effects 0.000 description 2
- 231100000386 immunotoxicity Toxicity 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 229910052594 sapphire Inorganic materials 0.000 description 2
- 239000010980 sapphire Substances 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- FZWBNHMXJMCXLU-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC(O)C(O)C(O)C(O)C=O)O1 FZWBNHMXJMCXLU-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 230000009946 DNA mutation Effects 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 241000416536 Euproctis pseudoconspersa Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 238000001446 dark-field microscopy Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 229960000443 hydrochloric acid Drugs 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000001465 metallisation Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000002076 thermal analysis method Methods 0.000 description 1
- 238000002207 thermal evaporation Methods 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
- C12M35/02—Electrical or electromagnetic means, e.g. for electroporation or for cell fusion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Definitions
- the present application is a Continuation-In-Part Application of International Application No. PCT/US2017/059720, filed Nov. 2, 2017, which claims the benefit of U.S. Provisional Application No. 62/416,857, filed Nov. 3, 2016.
- the present application also is a Continuation-In-Part Application of International Application No. PCT/US2017/059743, filed Nov. 2, 2017, which claims the benefit of U.S. Provisional Application No. 62/416,789, filed Nov. 3, 2016 and U.S. Provisional Application No. 62/442,293, filed Jan. 4, 2017 789.
- the disclosures of each of the above patent applications is hereby incorporated by reference in its entirety.
- This disclosure relates generally to substrates and methods for delivery of cargos to cells. More particularly, in some aspects, the present teachings relate to cellular poration and intracellular cargo delivery methods using laser radiation and thermoplasmonic substrates.
- Viral transduction is the most popular biological method due to decades of extensive research, but has limitations. For example, viral methods offer limited cargo-carrying capacity, only deliver genetic cargo, and include immunotoxicity risks.
- a method of cell processing includes disposing a plurality of cells on a substrate across which a plurality of projections are distributed and an electrically conductive layer at least partially coating said projections, exposing the cells to a cargo to be internalized by the cells, irradiating the substrate surface (and in particular the projections) with continuous or pulsed radiation.
- the radiation can have a wavelength in a range of about 200 nm to about 5 microns, and an intensity in a range of about 10 2 W/cm 2 to about 10 5 W/cm 2 , or in a range of about 10 3 W/cm 2 to about 10 4 W/cm 2 .
- a laser intensity of at least about 10 4 W/cm 2 can be used for delivery of a cargo into one or more cells. It has been unexpectedly discovered that even at such high intensities and fluences, many of the processed cells survive and divide.
- the continuous laser radiation can be applied to the substrate for a time duration of at least about 1 ms, e.g., for a time duration in a range of about 1 ms to about 500 ms.
- one or more laser pulses having a pulse width in a range of about 1 ns to about 1000 ns can be applied so as to facilitate uptake of the cargo by at least a portion of the cells (e.g., the cells positioned in the vicinity of the projections (e.g., within hundreds of nanometer (such as less than a few hundred nanometers (e.g., less than about 1000 nm) of the projections).
- the laser pulses have a pulse width in a range of about 10 ns to about 500 ns, e.g., in a range of about 20 ns to about 100 ns.
- the laser pulses are applied to the cells at a fluence in a range of about 0.01 mJ/cm 2 to about 1000 mJ/cm 2 , e.g., in a range of about 40 mJ/cm 2 to about 90 mJ/cm 2 , or in a range of about 50 mJ/cm 2 to about 80 mJ/cm 2 .
- the laser pulses are applied to the cells with a repetition rate in a range of about 0.1 Hz to about 100 GHz, e.g., in a range of about 1 Hz to about 100 Hz.
- the present invention provides methods of cell processing, which include disposing at least one cell on or near a structured metal surface, exposing the cell to at least an external cargo, and irradiating the metal surface with a continuous laser radiation at an intensity in a range of about 10 2 W/cm 2 to about 10 5 W/cm 2 so as to facilitate uptake of the cargo by the cell.
- the metal surface can be irradiated for at least about 1 ms.
- the structured metal surface includes a plurality of metalized projections, e.g., metalized pyramids.
- At least some of the cells in proximity of the pyramids can undergo a physical and/or chemical change, which can facilitate uptake of a cargo by those cells.
- the electrically conductive layer has a thickness in a range of about 1 nm to about 1 micron, e.g., in a range of about 20 nm to about 100 nm or in a range of about 10 nm to about 50 nm.
- the conductive layer can be formed of a plurality of different materials, such as gold, silver, copper, metallic titanium oxide, titanium, titanium nitride, platinum, palladium, chromium, among others.
- the electrically conductive coating has a substantially uniform thickness across the substrate. In some embodiments, the conductive coating continuously covers the projections and the surface portions between the projections.
- the projections are distributed across the substrate surface as a regular array, e.g., a regular two-dimensional array.
- the projections can form a two dimensional lattice, such as a hexagonal lattice.
- the projections are separated from one another by a spacing in a range of about 1 nm to about 500 ⁇ m, e.g., in a range of about 0.1 ⁇ m to about 100 ⁇ m or in a range of about 1 ⁇ m to about 50 ⁇ m or in a range of about 10 ⁇ m to about 30 ⁇ m.
- the projections have a substantially uniform height.
- the projections are a plurality of pyramids.
- the pyramids have a height, e.g., in a range of about 0.1 ⁇ m to about 20 ⁇ m, or a range of about 1 ⁇ m to about 10 ⁇ m.
- the pyramids have a base length, e.g., in a range of about 0.1 ⁇ m to about 100 ⁇ m, or in a range of about 1 ⁇ m to about 10 ⁇ m.
- the pyramids can have substantially uniform heights and base lengths.
- the pyramids are distributed across the substrate surface as a regular array (e.g., as a regular two-dimensional array). In some such embodiments, the pyramids are spaced from one another by a spacing in a range of about 1 nm to about 500 ⁇ m, e.g., in a range of about 0.1 ⁇ m to about 100 ⁇ m, or in a range of about 1 ⁇ m to about 10 ⁇ m.
- the applied laser radiation can cause a transient change in the cells sufficient to allow the uptake of one or more cargos in vicinity of the cells.
- a transient change can be a change in the permeability of the cell's membrane.
- the substrate comprises a polymer.
- polymers include, without limitation, polymethyl methacrylate, mercapto-ester, epoxy glue, UV glue, and polydimethylsiloxane.
- the substrate can be a semiconductor substrate (e.g., silicon, sapphire, and diamond).
- the substrate can be formed of glass.
- the introduction of a cargo into a plurality of cells can be achieved at an efficiency of at least about 40%, or at least about 50%, or at least about 60%, or at least about 70%, or at least about 80%, or at least 90%, e.g., in a range of about 85% to about 95%.
- the processed cells can exhibit a cell viability of at least about 70%, or at least about 80%, or at least about 90%, or at least about 95%, e.g., about 98% or greater.
- the introduction of a cargo into the processed cells can be achieved at a rate of at least about 10,000 cells/min, or at least about 20,000 cells/min, or at least about 30,000 cells/min, or at least about 40,000 cells/min, or at least about 50,000 cells/min, or at least about 100,000 cells/min, or at least 500,000 cells/min, or at least 1 million cells/min, or at least 10 million cell/min, or at least 100 million cells/min.
- the cargo can be a macromolecule.
- the cargo can be any of a deoxyribonucleic acid (DNA), a ribonucleic acid (RNA), a plasmid, a protein, a dye, a polymer, a quantum dot, a nanoparticle, a protein, a protein complex, and a polysaccharide.
- a Cas9/gRNA protein complex can be delivered to cells.
- the methods and substrates according to the present teachings can be employed to deliver cargos to a variety of different cell types.
- cell types include, without limitation, an epithelial cell, a neuron, a fibroblast, a stem cell, an immune cell (e.g., a T cell), and a blood cell.
- the cells can be mammalian cells.
- the application of the continuous or pulsed laser radiation to a metalized surface projection can cause a rise in temperature of at least a portion thereof.
- a temperature rise can be at least about 275° C., e.g., in a range of about 275° C. to about 500° C.
- the temperature rise is more pronounced in the vicinity of the tips of the pyramids.
- the cells and one or more cargos to be internalized by the cells are disposed in a liquid medium, e.g., a water-based medium, and the medium is applied to the substrate surface.
- the application of the continuous or pulsed laser radiation to the substrate can cause an increase in the temperatures of the projections (e.g., the pyramids), e.g., due to plasmonic excitation in the metal layer coating the projections.
- the temperature rise can be sufficient to cause formation of bubbles and/or pressure waves in the medium and around the cell membrane, which can in turn cause a change in the permeability of the cells, thus facilitating the uptake of nearby cargo(s) by the cells.
- a cell-processing substrate (herein also referred to as a thermoplasmonic substrate) is disclosed, which includes a substrate having a plurality of projections distributed across a surface thereof, and an electrically conductive layer at least partially covering the projections.
- the projections have a substantially uniform height.
- the conductive layer has a substantially uniform thickness.
- the projections have a pyramidal shape extending from a base to an apex.
- the pyramids have a height, e.g., in a range of about 0.1 ⁇ m to about 20 ⁇ m, or a range of about 1 ⁇ m to about 10 ⁇ m.
- the pyramids have a base length, e.g., in a range of about 0.1 ⁇ m to about 100 ⁇ m, or in a range of about 1 ⁇ m to about 10 ⁇ m.
- the pyramids can have substantially uniform heights and base lengths.
- the electrically conductive layer has a thickness in a range of about 1 nm to about 100 nm.
- the conductive layer has a substantially uniform thickness across the substrate surface. In some such embodiments, the conductive layer provides a uniform coating that substantially covers the entire substrate surface including the surfaces of the projections.
- the electrically conductive layer can be formed of a variety of different materials, such as a variety of different metals. Some examples of suitable conductive materials include, for example, silver, gold, copper and metallic titanium nitride.
- a cartridge which includes a cell-processing substrate having a metalized surface and an opposed back surface, a polymeric layer disposed in proximity of said metalized surface and separated therefrom by a gap to allow introduction of a sample onto the metalized surface.
- the cartridge can include another polymeric layer disposed in proximity of the back surface of the cell-processing substrate.
- each of the polymeric layers can include any of poly(methyl) methacrylate (PMMA) and polydimethylsiloxane (PDMS).
- a system for cell processing which includes a cartridge including a cell-processing substrate having a metalized surface comprising a plurality of projections at least partially coated with an electrically conductive coating, and a device for receiving said cartridge and exposing said metalized surface to laser radiation.
- the device can include an enclosure for receiving the cartridge. Further, the device can include a laser for generating laser radiation and a radiation scanning system for receiving the laser radiation and scanning the radiation over the metalized surface of the cartridge.
- FIG. 1 is a flow chart depicting various steps in an exemplary embodiment for delivering cargos to cells in accordance with aspects of the present disclosure
- FIG. 2 is a schematic representation of a perspective view of a cell-processing structure in accordance with an embodiment of the present disclosure
- FIG. 3 is a schematic representation of a front view of a cell-processing structure in accordance with an embodiment of the present disclosure
- FIG. 4 is a schematic representation of a pyramid of a cell-processing structure in accordance with an embodiment of the present disclosure
- FIG. 5 is a schematic diagram of an exemplary apparatus for delivering cargos to cells in accordance with an embodiment of the present disclosure
- FIG. 6A is a schematic representation of an experimental set-up for irradiating a substrate to deliver cargos to cells in accordance with aspects of the present disclosure
- FIG. 6B is an enlarged view of a portion of the experimental set-up depicted in FIG. 6A ;
- FIG. 6C is an enlarged an irradiated portion of a cell-processing substrate irradiated by a laser beam as shown in FIG. 6B ;
- FIGS. 7A-7J schematically depict various steps in a method for fabricating a thermoplasmonic substrate according to an embodiment of the present teachings
- FIG. 8A is an image of a thermoplasmonic substrate in accordance with an embodiment of the present disclosure.
- FIGS. 8B and 8C are, respectively, a scanning electron microscopy image of a top view and a side view of a thermoplasmonic substrate in accordance with an embodiment of the present disclosure
- FIGS. 9A and 9B show the results of Fine Element Method simulations of temperature profiles of a plurality of pyramids of a thermoplasmonic substrate according to an embodiment of the present teachings when illuminated with laser radiation;
- FIG. 9C presents a plurality of graphs depicting simulated temporal evolution of the maximum water temperature near nano-hotspots of a thermoplasmonic substrate in accordance with an embodiment of the present teachings for different laser fluences;
- FIG. 9D presents a plurality of graphs depicting simulated temporal evolution of the maximum temperature of water and gold associated with a thermoplasmonic substrate according to an embodiment of the present teachings for a laser fluence of 55 mJ/cm 2 ;
- FIG. 9E is a plurality of data points depicting simulated maximum temperature of water disposed on a thermoplasmonic substrate according to an embodiment of the present teachings and gold associated with the substrate for different laser fluences;
- FIG. 10 is a scanning electron microscopy image of a top view of a thermoplasmonic substrate according to an embodiment of the present teachings after laser illumination at a fluence of 200 mJ/cm 2 ;
- FIG. 11A is a scanning electron microscopy image of a chemically-fixed cell disposed on pyramids of a thermoplasmonic substrate according to an embodiment of the present teachings
- FIG. 11C is a confocal laser-scanning microscopy image of a cell closer to the bottom of the cell;
- FIG. 11D depicts z-stack cross section of the cell along the dotted white line shown in FIG. 11C ;
- FIG. 12A is an overlay of a bright-field and fluorescent images of cells disposed on different portions of a surface of a thermoplasmonic substrate according to an embodiment of the present teachings, where areas I and III have pyramids, areas II and IV are flat gold. The laser radiation was scanned below the dotted line, and area III was the only region in which green molecules were delivered to cells;
- FIG. 12C is a fluorescent image of cells after calcein green delivery in accordance with aspects of the present disclosure.
- FIG. 12D is a fluorescent image of cells depicting cell viability after delivery of calcein red-orange AM
- FIG. 12E is an image depicting an overlay of the images from FIG. 12C and FIG. 12D ;
- FIG. 12F is a scanning electron microscopy image of a top view of cells chemically fixed to a thermoplasmonic substrate according to an embodiment of the present disclosure
- FIG. 12G is an image depicting an overlay of the images from FIG. 12E and FIG. 12F ;
- FIG. 12H is an enlarged view of the portions of the FIG. 12G depicted in the rectangle;
- FIG. 13A is a scanning electron microscopy image of a top view of a thermoplasmonic substrate after delivering cargos to cells using a laser illumination at a fluence of 48 mJ/cm 2 ;
- FIG. 13B is a scanning electron microscopy image of a top view of a thermoplasmonic substrate after delivering cargos to cells using a laser illumination at a fluence of 52 mJ/cm 2 ;
- FIG. 13C is a Scanning Electron Microscopy image of a top view of a thermoplasmonic substrate after delivering cargos to cells using a laser illumination at a fluence of 56 mJ/cm 2 ;
- FIG. 13D is a Scanning Electron Microscopy image of a top view of a thermoplasmonic substrate after delivering cargos to cells using a laser illumination at a fluence of 60 mJ/cm 2 ;
- FIG. 14A is a fluorescent image of cells with 150 kDa FITC-Dextran in FITC channel (same scale bar as FIG. 14B );
- FIG. 14B is a fluorescent image of cells with 150 kDa FITC-Dextran in calcein AM channel(scale bar is 50 ⁇ m);
- FIG. 15A is a fluorescent image of cells with 150 kDa FITC-Dextran 24 hours after delivery in FITC-Dextran channel (scale bar, 50 ⁇ m);
- FIG. 15B is a fluorescent image of cells with 150 kDa FITC-Dextran 24 hours after delivery in calcein AM channel (scale bar, 50 ⁇ m);
- FIG. 15C is a fluorescent image of cells with 150 kDa FITC-Dextran 48 hours after delivery in FITC-Dextran channel (scale bar, 50 ⁇ m);
- FIG. 15D is a fluorescent image of cells with FITC-Dextran 150 kDa 48 hours after delivery in calcein AM channel (scale bar, 50 ⁇ m);
- FIG. 16 is a table presenting ICP-MS experimental information for Dextran 10 kDa delivery in accordance with aspects of the present disclosure
- FIG. 17 is a table depicting the reagent list for flow cytometry experiments.
- FIG. 18 is a table depicting sample information for flow cytometry data sets
- FIG. 19 is a table depicting flow cytometry settings on BD LSRFortessaSORPTM cell analyser running BD FACSDiva software version 6.1.3;
- FIG. 20A is a flow cytometry diagram depicting calcein red-orange AM flurorescence as a function of side scatter-area where the experimental sample was not laser scanned;
- FIG. 20B is a flow cytometry diagram depicting FITC-Dextran 150 kDa flurorescence as a function of side scatter-area where the experimental sample was not laser scanned;
- FIG. 20C is a flow cytometry diagram depicting calcein red-orange AM flurorescence as a function of side scatter-area where the experimental sample was laser scanned in accordance with aspects of the present disclosure
- FIG. 20D is a flow cytometry diagram depicting FITC-Dextran 150 kDa flurorescence as a function of side scatter-area where the experimental sample was laser scanned in accordance with aspects of the present disclosure
- FIG. 21A is a flow cytometry diagram depicting FSC-A as a function of SSC-A for FITC-dextran 150 kDa delivery and flat edge sample in accordance with aspects of the present disclosure
- FIG. 21B is a flow cytometry diagram depicting SSC-W as a function of SSH-C for FITC-dextran 150 kDa delivery and flat edge sample in accordance with aspects of the present disclosure
- FIG. 21C is a flow cytometry diagram depicting PE-A as a function of SSC-A for FITC-dextran 150 kDa delivery and flat edge sample in accordance with aspects of the present disclosure
- FIG. 21D is a flow cytometry diagram depicting FITC-A as a function of SSC-A for FITC-dextran 150 kDa delivery and flat edge sample in accordance with aspects of the present disclosure
- FIG. 21E is a flow cytometry diagram depicting FSC-A as a function of SSC-A for FITC-dextran 150 kDa delivery and no flat edge sample in accordance with aspects of the present disclosure
- FIG. 21F is a flow cytometry diagram depicting SSC-W as a function of SSH-C for FITC-dextran 150 kDa delivery and no flat edge sample in accordance with aspects of the present disclosure
- FIG. 21G is a flow cytometry diagram depicting PE-A as a function of SSC-A for FITC-dextran 150 kDa delivery and no flat edge sample in accordance with aspects of the present disclosure
- FIG. 21H is a flow cytometry diagram depicting FITC-A as a function of SSC-A for FITC-dextran 150 kDa delivery and no flat edge sample in accordance with aspects of the present disclosure
- FIG. 22A is a flow cytometry diagram depicting FSC-A as a function of SSC-A of a control blank sample to set initial gates in accordance with aspects of the present disclosure
- FIG. 22B is a flow cytometry diagram depicting SSC-W as a function of SSC-H of a control blank sample to set initial gates in accordance with aspects of the present disclosure
- FIG. 22C is a flow cytometry diagram depicting calcein AM red-orange fluorescence as a function of SSC-A of a control blank sample to set initial gates in accordance with aspects of the present disclosure
- FIG. 22D is a flow cytometry diagram depicting FITC-Dextran 10 kDa fluorescence as a function of SSC-A of a control blank sample to set initial gates in accordance with aspects of the present disclosure
- FIG. 22E is a flow cytometry diagram depicting FSC-A as a function of SSC-A of control sample to determine background of green dye and viability of cells when not laser scanned in accordance with aspects of the present disclosure
- FIG. 22F is a flow cytometry diagram depicting SSC-W as a function of SSC-H of control sample to determine background of green dye and viability of cells when not laser scanned in accordance with aspects of the present disclosure
- FIG. 22G is a flow cytometry diagram depicting calcein AM red-orange fluorescence as a function of SSC-A of a control sample to determine background of green dye and viability of cells when not laser scanned in accordance with aspects of the present disclosure
- FIG. 22H is a flow cytometry diagram depicting FITC-Dextran 10 kDa fluorescence as a function of SSC-A of a control sample to determine background of green dye and viability of cells when not laser scanned in accordance with aspects of the present disclosure
- FIG. 22I is a flow cytometry diagram depicting FSC-A as a function of SSC-A of a negative control sample for viability in accordance with aspects of the present disclosure
- FIG. 22J is a flow cytometry diagram depicting SSC-W as a function of SSC-H of a negative control sample for viability in accordance with aspects of the present disclosure
- FIG. 22K is a flow cytometry diagram depicting calcein AM red-orange fluorescence as a function of SSC-A of a negative control sample for viability in accordance with aspects of the present disclosure
- FIG. 22L is a flow cytometry diagram depicting FITC-Dextran 10 kDa fluorescence as a function of SSC-A of a negative control sample for viability in accordance with aspects of the present disclosure
- FIG. 22M is a flow cytometry diagram depicting FSC-A as a function of SSC-A of experimental sample in accordance with aspects of the present disclosure
- FIG. 22N is a flow cytometry diagram depicting SSC-W as a function of SSC-H of experimental sample in accordance with aspects of the present disclosure
- FIG. 22O is a flow cytometry diagram depicting calcein AM red-orange fluorescence as a function of SSC-A of experimental sample in accordance with aspects of the present disclosure
- FIG. 22P is a flow cytometry diagram depicting FITC-Dextran 10 kDa fluorescence as a function of SSC-A of experimental sample in accordance with aspects of the present disclosure
- FIG. 23A is a flow cytometry diagram depicting calcein green fluorescence as a function of SSC-A in accordance with aspects of the present disclosure
- FIG. 23B is a flow cytometry diagram depicting FITC-dextran 10 kDa fluorescence as a function of SSC-A in accordance with aspects of the present disclosure
- FIB. 23 C is a flow cytometry diagram depicting FITC-dextran 70 kDa fluorescence as a function of SSC-A in accordance with aspects of the present disclosure
- FIG. 23D is a flow cytometry diagram depicting FITC-dextran 150 kDa fluorescence as a function of SSC-A in accordance with aspects of the present disclosure
- FIG. 23E is a flow cytometry diagram depicting FITC-dextran 500 kDa fluorescence as a function of SSC-A in accordance with aspects of the present disclosure
- FIG. 23F is a flow cytometry diagram depicting FITC-dextran 2000 kDa fluorescence as a function of SSC-A in accordance with aspects of the present disclosure
- FIG. 24 schematically depicts a cartridge according to an embodiment, which includes a thermoplasmonic substrate according to the present teachings
- FIG. 25A is a top schematic view of a device according to an embodiment of the present teachings, which can receive the cartridge shown in FIG. 24 and expose its metalized surface to laser radiation;
- FIG. 25B is a perspective schematic view of the device depicted in FIG. 25A ;
- FIG. 26 schematically depicts the introduction of a sample, e.g., a sample containing cell, into the cartridge depicted in FIG. 24 .
- the present disclosure relates generally to substrates for use in processing cells and method of cells processing that allow causing changes in cells that facilitate uptake of cargos by the cells.
- a medium containing one or more cells and one or more cargos to be internalized by the cells is disposed on a substrate surface having a plurality of metalized projections.
- the application of continuous wave radiation or a plurality of laser pulses to the cells can mediate the uptake of the cargo(s) by the cells. It has been discovered that the use of nanosecond pulses in combination with a substrate having metalized projections as discussed herein leads to efficient introduction of many types of cargos into cells at a high cell viability.
- the substrates and the methods of the invention allow for the direct delivery of functional cargo to millions of cells on a minute timescale (e.g., at a rate of at least about 50,000 cells/min).
- a minute timescale e.g., at a rate of at least about 50,000 cells/min.
- Such a high throughput processing of cells can find applications in a variety of different areas, such as gene therapy, drug discovery, high-throughput screening, and the study of cellular function.
- a variety of different cargos can be delivered to cells using the substrates and the methods of the invention.
- cargos having molecular weights in a range of about 0.6 to 2000 KDa can be delivered to cells with a high efficiency (e.g., as high as 95%), a high viability (e.g., 98%).
- the application of laser radiation to the substrate can cause heating of the projections, particularly at their tips, which can in turn cause formation of bubbles and/or pressure waves in the medium in which the cells are entrained.
- bubbles can cause formation of transient pores in the cells' membranes, which can in turn facilitate the uptake of the cargo(s) by the cells.
- polymer is used herein consistent with its common meaning in the art to refer to a macromolecule formed by the chemical union of five or more repeating chemical units, e.g., by repeating monomers.
- “cargo” and “agent” as used herein refer to any compound, molecule, molecular complex, and/or biological organisms, such as plasmid or viruses.
- thermoplasmonic is used herein to refer to the behavior of metallic structures, such as nano-sized structures, that act as heaters by absorbing light energy and converting that energy into heat.
- the efficiency of uptake of a cargo by a plurality of cells refers to the percentage of cells that contain the cargo after undergoing thermoplasmonic intracellular delivery according to the present teachings.
- the cell viability as used herein refers to the percentage of cells that survive after undergoing thermoplasmonic intracellular delivery according to the present teachings.
- nanosecond pulse(s) refers to radiation pulse(s) having a pulse width in a range of about 1 nanosecond to about 1000 nanoseconds, e.g., in a range of about 1 nanosecond to about 500 nanoseconds.
- one or more cells can be disposed on a metalized surface 100 a of a cell-processing structure 100 (herein also referred to as a thermoplasmonic or cell-processing substrate) in presence of at least one cargo (herein also referred to as agent), such as a biological agent, and irradiated with one or more laser radiation pulses having a pulse width in a range of about 1 nanosecond to 1000 nanoseconds, e.g., in a range of about 1 nanosecond to about 500 nanoseconds, or in a range of about 20 nanoseconds to about 100 nanoseconds, or in a range of about 10 nanoseconds to about 50 nanoseconds so as to cause a transformation in cell(s) that facilitates the uptake of the agent by the cells.
- the transformation caused by the applied laser pulses can be a transient change in the permeability of the cells' membranes
- the cell-processing substrate 100 includes a support substrate 102 having a top surface 104 across which a plurality projections 106 in the form of pyramids are distributed.
- the pyramids 106 are distributed across the surface of the substrate 102 as a regular two-dimensional array.
- the pyramids 106 may be randomly distributed across the substrate surface.
- the pyramids can have a height (H) in a range of about 0.1 ⁇ m to about 20 ⁇ m, or a range of about 1 ⁇ m to about 10 ⁇ m.
- pyramidal surfaces can form an angle ( ⁇ ) of about 70.6 degrees relative to one another, as shown schematically in FIG. 4 .
- the pyramids 106 have a square base characterized by four equal sides having a size in a range of about 10 nm to about 500 ⁇ m, e.g., in a range of about 100 nm to 10 ⁇ m or in a range of about 100 ⁇ m to 400 ⁇ m.
- the pyramids 106 can have triangular bases.
- the spacing between neighboring pyramids can be, for example, in a range of about 1 nm to about 500 ⁇ m.
- the surface density of the pyramids (i.e., the number of pyramids per unit area of the substrate surface across which the pyramids are distributed) can be in a range of about 1 million /cm 2 to about 100 millions /cm 2 , e.g., in a range of about 10 millions/ cm 2 to about 100 millions/cm 2 , or in a range of about 20 millions/cm 2 to about 100 millions/cm 2 .
- a thin electrical conductive layer 300 such as a thin metal layer, coats the top surface of the substrate including the exposed pyramidal surfaces.
- the thickness of the metal layer can be, for example, in a range of about 1 nm to about 100 nm.
- a variety of metals can be used to form the metal layer 300 . Some suitable examples include gold, silver, and copper.
- the coating 300 can be formed of TiN.
- the substrate 102 can also be formed of a variety of different materials. In this embodiment, the substrate 102 is formed of a polymeric material.
- the substrate 102 can be formed of a semiconductor (e.g., silicon, sapphire, and diamond). In some embodiments, the substrate 102 can be formed of glass. In some embodiments, the substrate 102 can have a thickness in a range of about 10 nm to about 0.5 cm.
- a plurality of metalized cavities having inverse pyramidal shapes can be formed in a semiconductor substrate.
- the substrate can be used as a template to form a polymeric substrate having a plurality of metalized pyramidal projections distributed across a surface thereof.
- the methods according to the present teachings can be employed to deliver a variety of cargos, including organic, inorganic and/or biological agents to a cell.
- the cell's membrane is normally impermeable to such cargos.
- cargos include, without limitation, a deoxyribonucleir acid (DNA), a ribonucleic acid (RNA), an mRNA, a plasmid, a ribonuclear protein complex (RNP), a peptide, a protein, a dye, a drug, a therapeutic agent, among others.
- the present substrates and methods can be employed to deliver a Cas9/gRNA RNP system to a cell.
- molecules having a molecular weight in a range of about 500 Da to about 2,000,000 Da can be delivered to cells using the methods and substrates according to the present teachings.
- the present teachings can be used to deliver cargos to a plurality of different types of cells.
- suitable cells include, without limitation, an epithelial cell, a neuron, a fibroblast, a stem cell (e.g., a skin stem cell), an hematopoietic cell, an immune cell (e.g., a T cell), a blood cell, bacteria, a plant cell, a liver cell, and a pancreatic cell.
- the cells are Mammalian cells.
- FIG. 5 schematically depicts a system for illuminating cells disposed on a thermoplasmonic substrate according to the present teachings so as to deliver one or more cargos to the cells.
- the system 500 includes a laser source 501 (e.g., a Nd:Yag laser in this embodiment) that generates a plurality of laser pulses.
- a laser source 501 e.g., a Nd:Yag laser in this embodiment
- the laser pulsewidths can be in a range of about 1 ns to about 1000 ns, e.g., in a range of about 10 ns to about 20 ns.
- the laser pulses have a pulse width of about 11 ns.
- the laser pulses have a central wavelength of 1064 nm and a repetition rate of 50 Hz.
- the laser pulses pass through an isolator to prevent their back reflection and subsequently pass through a half-wave plate (HWP) 502 to rotate the plane of polarization of the laser pulses.
- the laser pulses then pass through a polarizer 504 .
- a pelican beam splitter 506 directs a small portion of the energy of the pulses onto an energy detector 508 for measuring the pulse energies, and allows transmission of the remainder of the laser energy to a lens 512 , which loosely focuses the pulses onto a substrate 514 , via reflection at the mirror 510 .
- the substrate can be seeded with a plurality of cells, typically disposed in a medium that contains one or more agents to be internalized by the cells.
- the substrate can be positioned on a movable X-Y stage that can be moved in two dimensions, e.g., at an average speed of about 10 mm/second, so as to expose different portions of the substrate on which the cells are disposed to the laser pulses.
- the central wavelength of the laser pulses can range from about 10 nm to about 2000 nm.
- the fluence of the laser pulses at the substrate can be in a range of about 0.01 mJ/cm 2 to about 1000 mJ/cm 2 , e.g., in a range of about 40 mJ/cm 2 to about 90 mJ/cm 2 , or in a range of about 50 mJ/cm 2 to about 80 mJ/cm 2 .
- FIGS. 6A, 6B, and 6C schematically depict that the laser beam 600 can concurrently illuminate a plurality of pyramids on or in proximity of which cells are disposed.
- the number of concurrently illuminated pyramids can be up to 500 million pyramids, e.g., in a range of about 100 million to about 500 million pyramids.
- the illumination of the pyramids by the continuous wave or pulsed laser radiation can in turn facilitate the uptake of one or more agents (e.g., molecules) on or in proximity of the pyramids (e.g., at a distance less than hundreds of nanometers (such as 1000 nm) relative to one or more pyramids).
- the method of the present teachings allow parallel processing of a plurality of cells, thus providing an efficient method for delivering cargos to cells.
- the methods of the present teachings can be used to deliver cargos to cells at an efficiency of at least about 40%, e.g., in a range of about 60% to about 90%, and a cell viability of at least about 60%, e.g., in a range of about 60% to about 95%.
- the electrical conductive layer 300 has a substantially uniform thickness across the substrate surface.
- the pyramidal projections can have substantially uniform heights and base lengths. Such uniformity can advantageously allow a consistent processing of cells disposed on different portions of the substrate surface.
- the methods according to the present teachings allow processing cells at a high throughput, e.g., at a throughput in a range of about 1 cell per min to about 500 million cells per minute, e.g., in a range of about 10 million cells per minute to about 500 million cells per minute, or in a range of about 50 million cells per minute to about 500 million cells per minute, or in a range of about 100 million cells per minute to about 500 million cells per minute.
- the methods discussed herein allow the introduction of cargos into a variety of cells at a high efficiency (e.g., an efficiency greater than about 80%, or greater than about 90%) and with a high cell viability (e.g., a cell viability greater than about 80%, or greater than about 90%).
- the use of the methods discussed herein for processing cells does not result in the introduction of cytoxic substances from the substrate (e.g., pieces of the conductive coating) into the processed cells.
- the present invention provides a cartridge comprising a plasmonic substrate according to the present teachings and a device that can receive such a cartridge and illuminate cells disposed on the plasmonic substrate.
- FIG. 24 schematically depicts a cartridge 2400 comprising a housing 2401 in which a cell-processing substrate 2402 according to the present teachings, such as those discussed above, is disposed.
- the cell-processing substrate 2402 can include a surface 2402 a (herein also referred to as a metalized surface) having a plurality of projections that are at least partially coated with an electrically conductive layer.
- the cell-processing substrate 2402 is disposed between two polymeric layers 2404 and 2406 .
- a gap 2408 between the metalized surface of the plasmonic substrate, i.e., the surface including the metal-coated pyramids, and the polymer layer 2406 allows injecting a sample containing cells onto the metalized surface of the plasmonic substrate 2402 a via a port 2407 provided in the cartridge housing.
- the cartridge housing and the polymeric layers 2404 and 2406 can be formed of a variety of different polymers.
- the cartridge housing can be formed of a polymer, such as polydimethylsiloxane (PDMS).
- PDMS polydimethylsiloxane
- Some suitable polymers for fabricating the polymeric layers 2404 and 2406 include, without limitation, PMMA and PDMS.
- FIGS. 25A and 25B schematically depict a device 2500 that can receive the cartridge 2400 and illuminate a sample disposed on its metalized surface.
- the device 2500 includes a housing 2502 in which various components of the device are disposed. More specifically, the device 2500 includes a laser head 2504 that contains a laser source, e.g., a diode laser, and the associated electronics for generating a laser beam for the illumination of a sample disposed on the metalized surface of a plasmonic substrate, as discussed in more detail below.
- a laser source e.g., a diode laser
- Some examples of laser include, without limitation, continuous-wave lasers and pulsed lasers, e.g., lasers generating nanosecond or femtosecond radiation.
- the housing 2502 further includes an enclosure 2506 having a slot 2506 a through which the cartridge 2400 can be inserted into the enclosure to be placed in the path of the laser beam generated by the laser head 2504 .
- an x-y scanning module 2508 can scan the laser beam over the metalized surface of the plasmonic substrate of the cartridge so as to illuminate different portions thereof, e.g., the portions in contact with the sample containing cells.
- the x-y scanning module can be implemented in a variety of different ways.
- the scanning module can include two rotatable mirrors that rotate about orthogonal axes.
- a beam splitter 2507 reflects a small portion of the laser beam to an energy meter 2509 while allowing the rest of the laser beam to pass therethrough to reach the x-y scanning module 2508 , which scans the beam over a sample disposed on the metalized surface of the cartridge.
- the polymeric layer 2406 is selected to be substantially transparent to the laser radiation, thereby allowing efficient illumination of a sample disposed on the metalized surface of the cell-processing substrate via the laser radiation.
- the device 2500 further includes a hardware module 2510 that can include control circuitry and associated electronics for operating and controlling the device, e.g., for controlling the scanning module and the laser.
- a hardware module 2510 can include control circuitry and associated electronics for operating and controlling the device, e.g., for controlling the scanning module and the laser.
- a user can introduce, e.g., via a syringe, a sample, e.g., a sample containing cells, onto the metalized surface of the cell-processing substrate contained in the plasmonic cartridge.
- the cartridge can then be inserted into the device 2500 to be exposed to laser radiation.
- the scanning module can scan the laser radiation over different locations of the metalized surface of the plasmonic substrate so as to expose portions of the sample disposed at those locations to the radiation.
- IPA isopropyl alcohol
- An SPR 700-1 photoresist 704 was spin-coated onto the wafer (3000 RPM, 45 s, ramp of 1000 RPM/s). The wafer was then soft baked (115° C., 60 s) ( FIG. 7B ). The entire area of the silicon wafer was exposed in an autostepper to form a grid-based pattern. A post-exposure bake was performed (115° C., 60 s). The wafer was then developed in CD-26 developer (1 min), then rinsed with deionized (DI) water (20 s). Development was repeated until no residue was released into the developer. The plasma stripper was then used to descum the wafer (100 W, 20 mT, 15 s) ( FIG. 7C ).
- DI deionized
- a chromium etch was performed (12 s, 15 angstroms/s etched, room temperature) to remove the Cr in the exposed squares. The sample was then washed with DI water and dried with an N 2 gun. The photoresist was removed in acetone. An O 2 plasma clean was performed (100 W, 20 mT, 3 min) to completely remove residual photoresist ( FIG. 7D ). An HF etch (4.9% HF) was used to remove oxide formed on the silicon ( 15 s). A KOH etch (2 parts water and 1 part of 45% KOH), was performed on a hotplate with a thermometer to form a plurality of inverted pyramids in the substrate (80° C., 3 min) ( FIG. 7E ). Chromium etching was performed to remove the hard mask (20 s, room temperature) ( FIG. 7F ).
- thermoplasmonic substrates were formed in the following way.
- a glass coverslip 708 (no. 1.5) was glued to the gold-coated master template with UV curable glue (Norland Adhesive 61) and cured under the UV lamp overnight ( FIG. 7H ).
- a thermoplasmonic substrate was peeled off (“template-strip”) from the template using a razor blade ( FIG. 7I ) resulting in a final substrate with about 10 million pyramids ( FIG. 7J ).
- template-strip UV curable glue
- FIG. 7I razor blade
- FIG. 7J By repeating gold deposition and template-stripping, large quantities of thermoplasmonic substrates were fabricated with high precision.
- the master template for the fabrication of the thermoplasmonic substrate can be re-used hundreds of times for template-stripping. This approach allows for low-cost, highly-p
- FIG. 8A shows an image of a thermoplasmonic substrate that is comparable in size to a U.S. quarter.
- FIGS. 8B and 8C show, respectively, a scanning electron microscopy (SEM) image of a top view, and an SEM image of a side view, of thermoplasmonic substrates formed using the above process. Characterization through SEM confirms that the pyramids of the template-stripped thermoplasmonic substrates are highly uniform in base lengths (2.4 ⁇ m), spacings (1.4 ⁇ m), and heights (1.4 ⁇ m), and consistent from batch to batch.
- SEM scanning electron microscopy
- FIGS. 9A-B Numerical simulations were performed to image the temperature profile of laser-irradiated pyramids ( FIGS. 9A-B ) of thermoplasmonic substrates and to determine the threshold laser fluence required for the temperature at the pyramidal apex of a thermoplasmonic substrate to reach the temperature range necessary to form bubbles within an aqueous environment ( FIGS. 9C-E ).
- thermoplasmonic substrates are effective nano-heaters due to the combined effect of their thin metal film, sharp apex, and gold composition, making them ideal for thermoplasmonic applications.
- Sharp metallic nanostructures are ideal for absorbing laser energy and concentrating the energy to hotspots that heat an aqueous environment and generate bubbles.
- the light-substrate interactions in an aqueous environment was simulated using a Finite Element Method (Comsol, Multiphyiscs 4.4).
- the three-dimensional electromagnetic interaction was calculated using the scattered field formulation under the assumptions that the spot size was large compared to the periodic pyramid structure (plane wave approximation) and that the optical properties of the polymer, gold film and adjacent water did not change during the interaction with the linearly polarized 11 ns (FWHM) Gaussian pulses.
- the geometrical parameters (pyramid base length: 2.4 ⁇ m; spacing: 1.2 ⁇ m; and thickness of the gold layer: 50 nm) were chosen to resemble those of the fabricated samples. Periodic boundary conditions in the x and y directions were applied.
- the simulation domain in the z-direction was truncated using perfectly matched layers (PML).
- the calculated laser energy absorbed was used as a transient heat source for a one-temperature model.
- the spatial and temporal evolution of the gold and water temperature was calculated for different laser fluences. More details about the setup of the simulation can be found in Demesy et al., “Tridimensional Multiphysics Model for the Study of Photo-induced Thermal Effects in Arbitrary Nano-structures”, JEOS:RP, 2011, vol. 6, 11037.
- the physical properties of gold and water were taken from Ekici et al., “Thermal Analysis of Gold Nanorods Heated with Femtosecond Laser Pulses” J. Phys. D Appl. Phys., 2008, 41(18), 185501. Properties of the UV glue were provided by the manufacturer.
- FIG. 9A shows a perspective view generated by Finite Element Method simulation of a thermoplasmonic substrate according to the present teachings, demonstrating that the thermoplasmonic pyramidal apexes reach a maximum temperature of 342° C. at a laser fluence of 45 mJ/cm 2 .
- FIG. 9B shows a top view generated by Finite Element Method simulation of a pyramid from the thermoplasmonic substrate depicting the temperature distribution of the pyramid.
- FIG. 9C shows a plurality of graphs depicting the temporal evolution of the maximum water temperature near nano-hotspots of a thermoplasmonic substrate for different laser fluences, and FIG.
- FIG. 9D shows a plurality of graphs depicting the temporal evolution of the maximum temperature of water and gold for a laser fluence of 55 mJ/cm 2 .
- the envelope of the excitation pulse is indicated in gray in both FIGS. 9C and 9D .
- FIG. 9E shows a the maximum water and gold temperature for different laser fluences.
- the simulation results show that for fluences above 40 mJ/cm 2 , the aqueous environment within tens of nanometers surrounding the pyramidal apex reaches temperatures above 300° C., which are within the temperature range for bubble formation.
- the critical temperature of water at 1 atm is in a range of 367° C. to 377° C., and thermodynamic theory and experimental studies show that explosive boiling occurs where temperatures reach 80-90% of this critical value, which corresponds to temperatures between 293-340° C.
- the laser experiments with cells were performed above the threshold laser fluence necessary for bubble formation ( 40 mJ/cm 2 ).
- FIG. 10 shows an SEM image of a top view of a thermoplasmonic substrate after laser illumination at a fluence of 200 mJ/cm 2 demonstrating the melting of the thin gold film above the pyramid and no visible effect on the polymer layer under the gold film.
- HeLa cells were seeded on thermoplasmonic substrates.
- HeLa CCL-2 cells were cultured in DMEM (10% FBS, 1% penicillin streptomycin) and incubated (37° C., 5% CO 2 ). Cells were passaged every other day, and used for experiments at 80% confluence, between passage numbers 15-30. Cells were washed with PBS (8 mL) and incubated (3 min) with trypsin (5 mL), before being neutralized with cell media (13 mL). Pipetting was used to wash the bottom of flask 5 times with the cell mixture before transferring the cell mixture to a tube (15 mL) and centrifuging it (5 min, 125 g).
- HeLa cells were chemically fixed on thermoplasmonic substrate. Samples were soaked in fixing solution (1 part 25% glutaraldehyde, 1 part 1M Hepes, 8 parts millipore water) ( ⁇ 10 min). Samples were soaked in buffer solution (2 parts 1M Hepes, 8 parts millipore water) and wrapped with parafilm before overnight storage (5° C.). The following day, the samples were rinsed by soaking in millipore water ( ⁇ 5 min). The samples were then dehydrated with ethanol by soaking them in 50% ethanol (5 min), 70% ethanol (5 min), 90% ethanol (5 min), 100% ethanol 3 times ( ⁇ 7 min each, total of 20-30 minutes), and 100% ethanol with molecular sieves (grade: 3 Angstrom) (7 min). Samples were finally soaked in HMDS 3 times ( ⁇ 7 min each, total 20-30 minutes) before air drying at room temperature.
- thermoplasmonic substrate The morphology of HeLa cells on thermoplasmonic substrate was imaged using scanning electron microscopy (SEM) and confocal microscopy techniques.
- FIG. 11A shows an SEM image of a chemically-fixed cell on pyramids of a thermoplasmonic substrate. Because chemical fixation kills the cell and alters the cell's lipid membranes, confocal microscopy was additionally used to image the morphology of a living cell that was fluorescently tagged with a cell-permeant dye for living cells ( FIGS. 11B-D ).
- FIG. 11A shows an SEM image of a chemically-fixed cell on pyramids of a thermoplasmonic substrate. Because chemical fixation kills the cell and alters the cell's lipid membranes, confocal microscopy was additionally used to image the morphology of a living cell that was fluorescent
- a z-stack cross section of the cell along the dotted white line from FIG. 11C is shown in FIG. 11D and depicts the membrane adhering to the pyramids. Both imaging methods indicate that each cell adheres to approximately 40-50 pyramids.
- thermoplasmonic substrates were laser scanned to perform intracellular delivery of cargo.
- Substrates with Hela cells on the surface were transferred to a petri dish (35 mm) and pre-warmed with PBS solution (2 mL, 37° C.) containing the molecules to be introduced into the cells (Calcein green at 500 ⁇ M or FITC-Dextran at 25 mg/mL).
- the laser setup ( FIG. 5 ) included an Nd:YAG source generating laser pulses at a wavelength of 1064 nm. The pulses were 11 ns in duration, with a repetition rate of 50 Hz.
- the laser passed through an optical isolator and a half-wave plate (HWP) and polarizer (P) that was controlling the laser energy passing through the setup.
- HWP half-wave plate
- P polarizer
- the half-wave plate was software-controlled, so the laser energy was changed remotely.
- a pelican beam splitter sent 8 % of the beam to an energy detector (ED) to constantly monitor the energy during an experiment.
- ED energy detector
- a lens (L) loosely focused the beam (1.2 mm in diameter) on the sample which sat on an x-y translational stage.
- the laser was scanned in a line across the sample, with each line at a different fluence. Longer distances were scanned to avoid cells being affected by the acceleration and deceleration of the stage (scan speed of 10 mm/s and ⁇ x of 100 mm), which can change the number of pulses hitting the sample and can affect the viability and efficiency of the technique.
- scan speed 10 mm/s and ⁇ x of 100 mm
- flow cytometry experiments FIGS. 16-19
- the petri dish contained the dye to be delivered in PBS solution. Negative control of areas with pyramids and no laser irradiation, and areas with no pyramids and no irradiation were performed on the same sample for each experiment.
- FIG. 12A shows a bright-field image overlaid with a fluorescent image with excitation and emission wavelengths of 495/515 nm, respectively of the cells after laser illumination with dissolved Calcein green molecules.
- Areas I and III contain gold-coated pyramids, whereas areas II and IV are flat gold. Areas III and IV were laser-scanned, while areas I and II were not. Only area III—the area containing gold-coated pyramids that was irradiated by the laser radiation—demonstrates the successful delivery of cell-impermeable Calcein green molecules to the cells.
- the efficiency of cargo delivery to HeLa cells that were cultured on the thermoplasmonic substrate and laser-scanned was determined using Calcein green molecule ( FIG. 12C ).
- An overlay of the efficiency and viability shows that cells with Calcein green delivered to the cytoplasm survive the experiment ( FIG. 12E ).
- the experiment was repeated at different laser fluences to determine the optimum laser fluence for maximum delivery efficiency and viability ( FIG. 12B ).
- the optimum fluence, where both efficiency (90%) and viability (95%) are maximized, was found to be 54 mJ/cm 2 . Simulation results previously discussed showed that the local temperature reaches 370° C. at this fluence, which is in the temperature range for bubble formation.
- FITC-dextran 150 kDa was delivered into the cytoplasm of the cells and distributed evenly within each cell ( FIG. 14A ) while keeping most of the cells viable ( FIG. 14B ).
- the proliferation of the cells after thermoplasmonic treatment was demonstrated using fluorescence microscopy.
- the cells were imaged after 24 hours and 48 hours of FITC-dextran 150 kDa delivery ( FIGS. 15A and 15C ) and Calcein AM delivery ( FIGS. 15B and 15D ).
- the cells showed the retention of FITC-dextran 150 kDa after 48 hours of delivery.
- the cells also showed an increase in density after 48 hours, indicating that the cells not only remain viable but continue to divide after laser illumination.
- ICP-MS inductively coupled plasma mass spectroscopy
- samples Prior to performing ICP-MS analysis, the samples were first weighed out on an analytical balance into clean BD Falcon tubes (15 ml) and then digested using ultrapure hydrochloric_acid overnight. The next day, samples were diluted to a desired volume (usually 5 or 10 ml) with deionized water. A fresh calibration curve was run with the sample. A method blank was run with the batch of samples (this was also used to calculate the detection limit) and calibration verification standards were run to calculate percent recoveries.
- FIG. 16 shows a table summarizing the results from the ICP-MS analysis for dextran 10 kDa cargo.
- Cells that undergo thermoplasmonic intracellular delivery had a signal that is representative of background noise, as did cells that were not in contact with gold.
- ICP-MS measurements on cells that were incubated with gold nanoparticles (and then washed several times to remove floating nanoparticles) exhibited greater gold content than background noise.
- ICP-MS verifies that no gold residue remains in the cells post-experiment, therefore excluding risks of gold fragment-induced mutagenesis.
- each FITC-cargo that was analyzed had 6 samples associated with it, including 3 control samples and 3 experimental samples using the conditions shown in the table presented in FIG. 18 .
- the samples were washed with PBS twice (10 mL and 1 mL). Trypsin (2 mL) was added in a dish (35 mm) and incubated (7 min) before neutralizing with pre-warmed cell media (5 mL). Cells were transferred to a tube (15 mL) and centrifuged (125 g, 5 min).
- FIGS. 20A-D show flow cytometry diagrams from FITC-Dextran 150 kDa experiments that compare viability and delivery efficiency of sample cells that were not laser-scanned ( FIGS. 16A-16B ) and sample cells that were laser-scanned ( FIG. 20C-20D ). Both sample cells were initially incubated in a solution containing the cargo to be delivered and then incubated in Calcein AM red-orange for viability indication. For the substrate that was not laser-scanned, the viability is 98.3% and the background signal for delivery is less than 1% ( FIG. 20A-20B ). For the laser-scanned substrate, the viability is 98.2% and the delivery efficiency is 74% ( FIG. 20C-20D ).
- FIG. 20E shows an histogram of the viability of cells and delivery efficiency of FITC-cargo ranging in size from 0.623 kDa to 2000 kDa.
- the largest cargo, FITC-Dextran 2000 kDa was delivered with an efficiency of 16%, and a viability of 97% ( FIGS. 20E ).
- the largest increase in efficiency was between FITC-Dextran 500 kDa (24%) and FITC-Dextran 150 kDa (68%).
- Calcein green (0.623 kDa) was delivered at 95% efficiency and 98% viability.
- the increased efficiency with decreasing cargo size was attributed to faster diffusion for smaller molecules.
- the delivered cargos match biologically relevant molecules and functional proteins in molecular weight (13 kDa to 150 kDa). Flow cytometry confirms that this technique offers high throughput, high viability, and high efficiency delivery of different cargo sizes.
- FIG. 20E The data in FIG. 20E are normalized by area of pyramids covering the surface. Regular coverslips were 18 by 18 mm, but only 14 by 14 mm of that area was covered in pyramids, the rest was flat gold, where cells do not have cargo delivered to them when scanned with a laser. Therefore flow cytometry experiments for area normalization were performed from FITC-Dextran 150 kDa samples having flat edge ( FIG. 21A-D ) and no flat edge ( FIG. 21E-H ). In the regular samples (with flat edge), an average efficiency of 48.89% for FITC-Dextran 150 kDa was obtained.
- a triplicate set of experiments with FITC-150 kDa was done on a sample with no flat gold, only pyramids all across on a 14 by 14 mm area, and an efficiency of 67.67% was obtained.
- the scaling factor of 1.38 (67.67%/48.89%) was used to normalize the efficiency for the different cargos according to surface coverage of the pyramids.
- FIGS. 22A-P show presentative flow cytometry data for an entire data set for FITC-Dextran 10 kDa experiments including the data from the control blank sample to set the initial gates ( FIGS. 22A-D , Sample ID B0), the control sample to determine the background for green dye and the viability of cells without laser scan ( FIG. 22E-H , Sample ID G0R0), the negative control sample to determine the viability ( FIG. 22 I-L, Sample ID G1), and the experimental samples in triplicate ( FIG. 22 M-P, Sample ID E1).
- FIGS. 23A-F show the flow cytometry diagrams for different-sized cargos such as the Calcein green 0.623 kDa ( FIG. 23A ), FITC-Dextran 10 kDa ( FIG. 23A ), FITC-Dextran 70 kDa ( FIG. 23A ), FITC-Dextran 150 kDa ( FIG. 23A ), FITC-Dextran 500 kDa ( FIG. 23A ), and FITC-Dextran 2000 kDa ( FIG. 23A ).
- cargos such as the Calcein green 0.623 kDa ( FIG. 23A ), FITC-Dextran 10 kDa ( FIG. 23A ), FITC-Dextran 70 kDa ( FIG. 23A ), FITC-Dextran 150 kDa ( FIG. 23A ), FITC-Dextran 500 kDa ( FIG. 23A ), and FITC-Dextran 2000 kDa ( FIG
- Samples containing HeLa cells and a cargo were seeded on the thermoplasmonic substrates, and the substrates were irradiated with continuous laser radiation using a fiber coupled JDSU diode laser at a wavelength of 980 nm, a power of 500 mW, and an intensity of 10 4 W/cm 2 to deliver the cargo to the cells. More specifically, the samples were positioned in a petri dish and immersed in a solution containing dissolved cargos to be delivered to the cells. The laser beam was focused on the substrate and the petri dish was fixed on an x-y movable stage to scan the sample at a determined speed (which is related to the laser exposure time).
- thermoplasmonic substrate can be reused for repeated high efficiency poration as the substrate undergoes no damage after laser irradiation.
- thermoplasmonic substrates with seeded cells were scanned while changing the laser intensity in order to change the cell metabolism.
- the change in cell metabolism of HeLa cells was measured using intense continuous wave laser illumination where the efficiency of FITC-dextran 150 kDa delivery (green) and viability (magenta) was observed for 3 days, i.e., day 0, day 1, and day 2.
- the columns were scanned from top to bottom while the laser intensity was increased in discrete steps.
- the cells exhibited a decrease in enzymatic activity (as shown by observed magenta) as the laser intensity increased.
- On day 1 some of the cells recovered.
- On day 2 some of the cells underwent cell death. Many cells retained the FITC-Dextran 150 kDa that was delivered to them over several days
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Sustainable Development (AREA)
- Electromagnetism (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
Description
- The present application is a Continuation-In-Part Application of International Application No. PCT/US2017/059720, filed Nov. 2, 2017, which claims the benefit of U.S. Provisional Application No. 62/416,857, filed Nov. 3, 2016. The present application also is a Continuation-In-Part Application of International Application No. PCT/US2017/059743, filed Nov. 2, 2017, which claims the benefit of U.S. Provisional Application No. 62/416,789, filed Nov. 3, 2016 and U.S. Provisional Application No. 62/442,293, filed Jan. 4, 2017 789. The disclosures of each of the above patent applications is hereby incorporated by reference in its entirety.
- The present invention was made with United States government support under Grant Nos. PHY 1219334 and PHY-1205465 from the National Science Foundation. The United States government has certain rights in this invention.
- This disclosure relates generally to substrates and methods for delivery of cargos to cells. More particularly, in some aspects, the present teachings relate to cellular poration and intracellular cargo delivery methods using laser radiation and thermoplasmonic substrates.
- The direct intracellular delivery of biological and non-biological materials is a powerful way to manipulate cell behavior for a wide range of applications. For example, functional proteins are delivered to ablate genes in hematopoietic stem cells with high precision for research and therapeutic applications. Enzymes are delivered for their ability to bind targets with high affinity and specificity and siRNA delivery has created opportunities in gene silencing for biomedical applications. In the case of blood disorders such as human immunodeficiency virus (HIV) or leukemia, delivering functional molecules into a patient's stem cells for transplantation therapy shows promise for curing such disorders, circumventing the side effects of chemotherapy and the search for a matching donor.
- [5] The ability to effectively deliver large and diverse cargos such as, without limitation, amino acids, peptides, proteins, protein cages, antibodies, polysaccharides, nucleic acids, viruses, or DNAs/RNAs directly into cells would be a huge boost for biomedical research. However, no current intracellular delivery method, either biological, chemical or physical, can offer all desirable “high-performance” features for intracellular delivery at once: (1) high efficiency, viability, and throughput, (2) diverse cargo delivery capability, (3) spatial selectivity (delivering to specific cells disposed on a surface), scalability and reproducibility, (4) no post-delivery immunotoxicity, and (5) cost-effectiveness.
- Viral transduction is the most popular biological method due to decades of extensive research, but has limitations. For example, viral methods offer limited cargo-carrying capacity, only deliver genetic cargo, and include immunotoxicity risks.
- Accordingly, there is a need for enhanced substrates and methods for intracellular delivery of diverse cargos into cells.
- In one aspect, a method of cell processing is disclosed, which includes disposing a plurality of cells on a substrate across which a plurality of projections are distributed and an electrically conductive layer at least partially coating said projections, exposing the cells to a cargo to be internalized by the cells, irradiating the substrate surface (and in particular the projections) with continuous or pulsed radiation.
- When continuous radiation is applied, the radiation can have a wavelength in a range of about 200 nm to about 5 microns, and an intensity in a range of about 102 W/cm2 to about 105 W/cm2, or in a range of about 103 W/cm2 to about 104 W/cm2. By way of example, in some embodiments, a laser intensity of at least about 104 W/cm2 can be used for delivery of a cargo into one or more cells. It has been unexpectedly discovered that even at such high intensities and fluences, many of the processed cells survive and divide. The continuous laser radiation can be applied to the substrate for a time duration of at least about 1 ms, e.g., for a time duration in a range of about 1 ms to about 500 ms.
- When pulsed radiation is employed, one or more laser pulses having a pulse width in a range of about 1 ns to about 1000 ns can be applied so as to facilitate uptake of the cargo by at least a portion of the cells (e.g., the cells positioned in the vicinity of the projections (e.g., within hundreds of nanometer (such as less than a few hundred nanometers (e.g., less than about 1000 nm) of the projections). In some embodiments, the laser pulses have a pulse width in a range of about 10 ns to about 500 ns, e.g., in a range of about 20 ns to about 100 ns.
- In some embodiments, the laser pulses are applied to the cells at a fluence in a range of about 0.01 mJ/cm2 to about 1000 mJ/cm2, e.g., in a range of about 40 mJ/cm2 to about 90 mJ/cm2, or in a range of about 50 mJ/cm2 to about 80 mJ/cm2.
- In some embodiments, the laser pulses are applied to the cells with a repetition rate in a range of about 0.1 Hz to about 100 GHz, e.g., in a range of about 1 Hz to about 100 Hz.
- In another aspect, the present invention provides methods of cell processing, which include disposing at least one cell on or near a structured metal surface, exposing the cell to at least an external cargo, and irradiating the metal surface with a continuous laser radiation at an intensity in a range of about 102 W/cm2 to about 105 W/cm2 so as to facilitate uptake of the cargo by the cell. By way of example, the metal surface can be irradiated for at least about 1 ms. In some embodiments, the structured metal surface includes a plurality of metalized projections, e.g., metalized pyramids. In some such embodiments, upon irradiation of the metalized pyramids, at least some of the cells in proximity of the pyramids (e.g., cells positioned within hundreds of nanometers (e.g., 1000 nm)) can undergo a physical and/or chemical change, which can facilitate uptake of a cargo by those cells.
- In some embodiments, the electrically conductive layer has a thickness in a range of about 1 nm to about 1 micron, e.g., in a range of about 20 nm to about 100 nm or in a range of about 10 nm to about 50 nm. The conductive layer can be formed of a plurality of different materials, such as gold, silver, copper, metallic titanium oxide, titanium, titanium nitride, platinum, palladium, chromium, among others.
- In some embodiments, the electrically conductive coating has a substantially uniform thickness across the substrate. In some embodiments, the conductive coating continuously covers the projections and the surface portions between the projections.
- In some embodiments, the projections are distributed across the substrate surface as a regular array, e.g., a regular two-dimensional array. For example, the projections can form a two dimensional lattice, such as a hexagonal lattice. In some such embodiments, the projections are separated from one another by a spacing in a range of about 1 nm to about 500 μm, e.g., in a range of about 0.1 μm to about 100 μm or in a range of about 1 μm to about 50 μm or in a range of about 10 μm to about 30 μm.
- In some embodiments, the projections have a substantially uniform height. In some embodiments, the projections are a plurality of pyramids. In some such embodiments, the pyramids have a height, e.g., in a range of about 0.1 μm to about 20 μm, or a range of about 1 μm to about 10 μm. Further, in some such embodiments, the pyramids have a base length, e.g., in a range of about 0.1 μm to about 100 μm, or in a range of about 1 μm to about 10 μm. In many embodiments, the pyramids can have substantially uniform heights and base lengths. In some embodiments, the pyramids are distributed across the substrate surface as a regular array (e.g., as a regular two-dimensional array). In some such embodiments, the pyramids are spaced from one another by a spacing in a range of about 1 nm to about 500 μm, e.g., in a range of about 0.1 μm to about 100 μm, or in a range of about 1 μm to about 10 μm.
- In some embodiments, the applied laser radiation can cause a transient change in the cells sufficient to allow the uptake of one or more cargos in vicinity of the cells. By way of example, such a transient change can be a change in the permeability of the cell's membrane.
- In some embodiments, the substrate comprises a polymer. Some examples of such polymers include, without limitation, polymethyl methacrylate, mercapto-ester, epoxy glue, UV glue, and polydimethylsiloxane. In some embodiments, the substrate can be a semiconductor substrate (e.g., silicon, sapphire, and diamond). In some embodiments, the substrate can be formed of glass. In some embodiments, the introduction of a cargo into a plurality of cells can be achieved at an efficiency of at least about 40%, or at least about 50%, or at least about 60%, or at least about 70%, or at least about 80%, or at least 90%, e.g., in a range of about 85% to about 95%. Further, in some embodiments, the processed cells can exhibit a cell viability of at least about 70%, or at least about 80%, or at least about 90%, or at least about 95%, e.g., about 98% or greater.
- In some embodiments, the introduction of a cargo into the processed cells can be achieved at a rate of at least about 10,000 cells/min, or at least about 20,000 cells/min, or at least about 30,000 cells/min, or at least about 40,000 cells/min, or at least about 50,000 cells/min, or at least about 100,000 cells/min, or at least 500,000 cells/min, or at least 1 million cells/min, or at least 10 million cell/min, or at least 100 million cells/min.
- A variety of different cargos can be delivered to cells using the substrates and the methods discussed herein. By way of example, the cargo can be a macromolecule. In some embodiments, the cargo can be any of a deoxyribonucleic acid (DNA), a ribonucleic acid (RNA), a plasmid, a protein, a dye, a polymer, a quantum dot, a nanoparticle, a protein, a protein complex, and a polysaccharide. In some embodiments, a Cas9/gRNA protein complex can be delivered to cells.
- Further, the methods and substrates according to the present teachings can be employed to deliver cargos to a variety of different cell types. Some examples of cell types include, without limitation, an epithelial cell, a neuron, a fibroblast, a stem cell, an immune cell (e.g., a T cell), and a blood cell. In some embodiments, the cells can be mammalian cells.
- In some embodiments, the application of the continuous or pulsed laser radiation to a metalized surface projection can cause a rise in temperature of at least a portion thereof. By way of example, such a temperature rise can be at least about 275° C., e.g., in a range of about 275° C. to about 500° C. In some embodiments in which the projections are in the form of a plurality of pyramids, the temperature rise is more pronounced in the vicinity of the tips of the pyramids.
- In some embodiments, the cells and one or more cargos to be internalized by the cells are disposed in a liquid medium, e.g., a water-based medium, and the medium is applied to the substrate surface. In some such embodiments, the application of the continuous or pulsed laser radiation to the substrate can cause an increase in the temperatures of the projections (e.g., the pyramids), e.g., due to plasmonic excitation in the metal layer coating the projections. In some cases, the temperature rise can be sufficient to cause formation of bubbles and/or pressure waves in the medium and around the cell membrane, which can in turn cause a change in the permeability of the cells, thus facilitating the uptake of nearby cargo(s) by the cells.
- In a related aspect, a cell-processing substrate (herein also referred to as a thermoplasmonic substrate) is disclosed, which includes a substrate having a plurality of projections distributed across a surface thereof, and an electrically conductive layer at least partially covering the projections. In some embodiments, the projections have a substantially uniform height. Further, in some embodiments, the conductive layer has a substantially uniform thickness.
- In some embodiments, the projections have a pyramidal shape extending from a base to an apex. In some such embodiments, the pyramids have a height, e.g., in a range of about 0.1 μm to about 20 μm, or a range of about 1 μm to about 10 μm. Further, in some such embodiments, the pyramids have a base length, e.g., in a range of about 0.1 μm to about 100 μm, or in a range of about 1 μm to about 10 μm. In many embodiments, the pyramids can have substantially uniform heights and base lengths. In some embodiments, the electrically conductive layer has a thickness in a range of about 1 nm to about 100 nm. In some embodiments, the conductive layer has a substantially uniform thickness across the substrate surface. In some such embodiments, the conductive layer provides a uniform coating that substantially covers the entire substrate surface including the surfaces of the projections. The electrically conductive layer can be formed of a variety of different materials, such as a variety of different metals. Some examples of suitable conductive materials include, for example, silver, gold, copper and metallic titanium nitride.
- In another aspect, a cartridge is disclosed, which includes a cell-processing substrate having a metalized surface and an opposed back surface, a polymeric layer disposed in proximity of said metalized surface and separated therefrom by a gap to allow introduction of a sample onto the metalized surface. In some embodiments, the cartridge can include another polymeric layer disposed in proximity of the back surface of the cell-processing substrate. By way of example, each of the polymeric layers can include any of poly(methyl) methacrylate (PMMA) and polydimethylsiloxane (PDMS).
- In a related aspect, a system for cell processing is disclosed, which includes a cartridge including a cell-processing substrate having a metalized surface comprising a plurality of projections at least partially coated with an electrically conductive coating, and a device for receiving said cartridge and exposing said metalized surface to laser radiation.
- In some embodiments of the above system, the device can include an enclosure for receiving the cartridge. Further, the device can include a laser for generating laser radiation and a radiation scanning system for receiving the laser radiation and scanning the radiation over the metalized surface of the cartridge.
- Further understanding of various aspects of the invention can be obtained by reference to the following detailed description in conjunction with the associated drawings, which are described briefly below.
- The present disclosure is described with reference to the following figures, which are presented for the purpose of illustration only and are not intended to be limiting.
- In the Drawings:
-
FIG. 1 is a flow chart depicting various steps in an exemplary embodiment for delivering cargos to cells in accordance with aspects of the present disclosure; -
FIG. 2 is a schematic representation of a perspective view of a cell-processing structure in accordance with an embodiment of the present disclosure; -
FIG. 3 is a schematic representation of a front view of a cell-processing structure in accordance with an embodiment of the present disclosure; -
FIG. 4 is a schematic representation of a pyramid of a cell-processing structure in accordance with an embodiment of the present disclosure; -
FIG. 5 is a schematic diagram of an exemplary apparatus for delivering cargos to cells in accordance with an embodiment of the present disclosure; -
FIG. 6A is a schematic representation of an experimental set-up for irradiating a substrate to deliver cargos to cells in accordance with aspects of the present disclosure; -
FIG. 6B is an enlarged view of a portion of the experimental set-up depicted inFIG. 6A ; -
FIG. 6C is an enlarged an irradiated portion of a cell-processing substrate irradiated by a laser beam as shown inFIG. 6B ; -
FIGS. 7A-7J schematically depict various steps in a method for fabricating a thermoplasmonic substrate according to an embodiment of the present teachings; -
FIG. 8A is an image of a thermoplasmonic substrate in accordance with an embodiment of the present disclosure; -
FIGS. 8B and 8C are, respectively, a scanning electron microscopy image of a top view and a side view of a thermoplasmonic substrate in accordance with an embodiment of the present disclosure; -
FIGS. 9A and 9B show the results of Fine Element Method simulations of temperature profiles of a plurality of pyramids of a thermoplasmonic substrate according to an embodiment of the present teachings when illuminated with laser radiation; -
FIG. 9C presents a plurality of graphs depicting simulated temporal evolution of the maximum water temperature near nano-hotspots of a thermoplasmonic substrate in accordance with an embodiment of the present teachings for different laser fluences; -
FIG. 9D presents a plurality of graphs depicting simulated temporal evolution of the maximum temperature of water and gold associated with a thermoplasmonic substrate according to an embodiment of the present teachings for a laser fluence of 55 mJ/cm2; -
FIG. 9E is a plurality of data points depicting simulated maximum temperature of water disposed on a thermoplasmonic substrate according to an embodiment of the present teachings and gold associated with the substrate for different laser fluences; -
FIG. 10 is a scanning electron microscopy image of a top view of a thermoplasmonic substrate according to an embodiment of the present teachings after laser illumination at a fluence of 200 mJ/cm2; -
FIG. 11A is a scanning electron microscopy image of a chemically-fixed cell disposed on pyramids of a thermoplasmonic substrate according to an embodiment of the present teachings; -
FIG. 11B is a confocal laser-scanning microscopy image of a slice of a cell (40 μm in length) with calcein red-orange AM fluorescence at z=8.85 μm as measured from the bottom of the cell; -
FIG. 11C is a confocal laser-scanning microscopy image of a cell closer to the bottom of the cell; -
FIG. 11D depicts z-stack cross section of the cell along the dotted white line shown inFIG. 11C ; -
FIG. 12A is an overlay of a bright-field and fluorescent images of cells disposed on different portions of a surface of a thermoplasmonic substrate according to an embodiment of the present teachings, where areas I and III have pyramids, areas II and IV are flat gold. The laser radiation was scanned below the dotted line, and area III was the only region in which green molecules were delivered to cells; -
FIG. 12B is a plurality of graphs depicting the delivery efficiency and viability as a function of laser fluence (data represent mean±SE from n=3 independent experiments) for cells disposed on a thermoplasmonic substrate in accordance with an embodiment of the present disclosures; -
FIG. 12C is a fluorescent image of cells after calcein green delivery in accordance with aspects of the present disclosure; -
FIG. 12D is a fluorescent image of cells depicting cell viability after delivery of calcein red-orange AM; -
FIG. 12E is an image depicting an overlay of the images fromFIG. 12C andFIG. 12D ; -
FIG. 12F is a scanning electron microscopy image of a top view of cells chemically fixed to a thermoplasmonic substrate according to an embodiment of the present disclosure; -
FIG. 12G is an image depicting an overlay of the images fromFIG. 12E andFIG. 12F ; -
FIG. 12H is an enlarged view of the portions of theFIG. 12G depicted in the rectangle; -
FIG. 13A is a scanning electron microscopy image of a top view of a thermoplasmonic substrate after delivering cargos to cells using a laser illumination at a fluence of 48 mJ/cm2; -
FIG. 13B is a scanning electron microscopy image of a top view of a thermoplasmonic substrate after delivering cargos to cells using a laser illumination at a fluence of 52 mJ/cm2; -
FIG. 13C is a Scanning Electron Microscopy image of a top view of a thermoplasmonic substrate after delivering cargos to cells using a laser illumination at a fluence of 56 mJ/cm2; -
FIG. 13D is a Scanning Electron Microscopy image of a top view of a thermoplasmonic substrate after delivering cargos to cells using a laser illumination at a fluence of 60 mJ/cm2; -
FIG. 14A is a fluorescent image of cells with 150 kDa FITC-Dextran in FITC channel (same scale bar asFIG. 14B ); -
FIG. 14B is a fluorescent image of cells with 150 kDa FITC-Dextran in calcein AM channel(scale bar is 50 μm); -
FIG. 15A is a fluorescent image of cells with 150 kDa FITC-Dextran 24 hours after delivery in FITC-Dextran channel (scale bar, 50 μm); -
FIG. 15B is a fluorescent image of cells with 150 kDa FITC-Dextran 24 hours after delivery in calcein AM channel (scale bar, 50 μm); -
FIG. 15C is a fluorescent image of cells with 150 kDa FITC-Dextran 48 hours after delivery in FITC-Dextran channel (scale bar, 50 μm); -
FIG. 15D is a fluorescent image of cells with FITC-Dextran 150 kDa 48 hours after delivery in calcein AM channel (scale bar, 50 μm); -
FIG. 16 is a table presenting ICP-MS experimental information forDextran 10 kDa delivery in accordance with aspects of the present disclosure; -
FIG. 17 is a table depicting the reagent list for flow cytometry experiments; -
FIG. 18 is a table depicting sample information for flow cytometry data sets; -
FIG. 19 is a table depicting flow cytometry settings on BD LSRFortessaSORP™ cell analyser running BD FACSDiva software version 6.1.3; -
FIG. 20A is a flow cytometry diagram depicting calcein red-orange AM flurorescence as a function of side scatter-area where the experimental sample was not laser scanned; -
FIG. 20B is a flow cytometry diagram depicting FITC-Dextran 150 kDa flurorescence as a function of side scatter-area where the experimental sample was not laser scanned; -
FIG. 20C is a flow cytometry diagram depicting calcein red-orange AM flurorescence as a function of side scatter-area where the experimental sample was laser scanned in accordance with aspects of the present disclosure; -
FIG. 20D is a flow cytometry diagram depicting FITC-Dextran 150 kDa flurorescence as a function of side scatter-area where the experimental sample was laser scanned in accordance with aspects of the present disclosure; -
FIG. 20E is a histogram depicting the viability and efficiency for delivery of FITC-cargo ranging in size from 0.623 kDa to 2000 kDa (the data represent mean±SE from n=3 independent experiments) in accordance with aspects of the present disclosure; -
FIG. 21A is a flow cytometry diagram depicting FSC-A as a function of SSC-A for FITC-dextran 150 kDa delivery and flat edge sample in accordance with aspects of the present disclosure; -
FIG. 21B is a flow cytometry diagram depicting SSC-W as a function of SSH-C for FITC-dextran 150 kDa delivery and flat edge sample in accordance with aspects of the present disclosure; -
FIG. 21C is a flow cytometry diagram depicting PE-A as a function of SSC-A for FITC-dextran 150 kDa delivery and flat edge sample in accordance with aspects of the present disclosure; -
FIG. 21D is a flow cytometry diagram depicting FITC-A as a function of SSC-A for FITC-dextran 150 kDa delivery and flat edge sample in accordance with aspects of the present disclosure; -
FIG. 21E is a flow cytometry diagram depicting FSC-A as a function of SSC-A for FITC-dextran 150 kDa delivery and no flat edge sample in accordance with aspects of the present disclosure; -
FIG. 21F is a flow cytometry diagram depicting SSC-W as a function of SSH-C for FITC-dextran 150 kDa delivery and no flat edge sample in accordance with aspects of the present disclosure; -
FIG. 21G is a flow cytometry diagram depicting PE-A as a function of SSC-A for FITC-dextran 150 kDa delivery and no flat edge sample in accordance with aspects of the present disclosure; -
FIG. 21H is a flow cytometry diagram depicting FITC-A as a function of SSC-A for FITC-dextran 150 kDa delivery and no flat edge sample in accordance with aspects of the present disclosure; -
FIG. 22A is a flow cytometry diagram depicting FSC-A as a function of SSC-A of a control blank sample to set initial gates in accordance with aspects of the present disclosure; -
FIG. 22B is a flow cytometry diagram depicting SSC-W as a function of SSC-H of a control blank sample to set initial gates in accordance with aspects of the present disclosure; -
FIG. 22C is a flow cytometry diagram depicting calcein AM red-orange fluorescence as a function of SSC-A of a control blank sample to set initial gates in accordance with aspects of the present disclosure; -
FIG. 22D is a flow cytometry diagram depicting FITC-Dextran 10 kDa fluorescence as a function of SSC-A of a control blank sample to set initial gates in accordance with aspects of the present disclosure; -
FIG. 22E is a flow cytometry diagram depicting FSC-A as a function of SSC-A of control sample to determine background of green dye and viability of cells when not laser scanned in accordance with aspects of the present disclosure; -
FIG. 22F is a flow cytometry diagram depicting SSC-W as a function of SSC-H of control sample to determine background of green dye and viability of cells when not laser scanned in accordance with aspects of the present disclosure; -
FIG. 22G is a flow cytometry diagram depicting calcein AM red-orange fluorescence as a function of SSC-A of a control sample to determine background of green dye and viability of cells when not laser scanned in accordance with aspects of the present disclosure; -
FIG. 22H is a flow cytometry diagram depicting FITC-Dextran 10 kDa fluorescence as a function of SSC-A of a control sample to determine background of green dye and viability of cells when not laser scanned in accordance with aspects of the present disclosure; -
FIG. 22I is a flow cytometry diagram depicting FSC-A as a function of SSC-A of a negative control sample for viability in accordance with aspects of the present disclosure; -
FIG. 22J is a flow cytometry diagram depicting SSC-W as a function of SSC-H of a negative control sample for viability in accordance with aspects of the present disclosure; -
FIG. 22K is a flow cytometry diagram depicting calcein AM red-orange fluorescence as a function of SSC-A of a negative control sample for viability in accordance with aspects of the present disclosure; -
FIG. 22L is a flow cytometry diagram depicting FITC-Dextran 10 kDa fluorescence as a function of SSC-A of a negative control sample for viability in accordance with aspects of the present disclosure; -
FIG. 22M is a flow cytometry diagram depicting FSC-A as a function of SSC-A of experimental sample in accordance with aspects of the present disclosure; -
FIG. 22N is a flow cytometry diagram depicting SSC-W as a function of SSC-H of experimental sample in accordance with aspects of the present disclosure; -
FIG. 22O is a flow cytometry diagram depicting calcein AM red-orange fluorescence as a function of SSC-A of experimental sample in accordance with aspects of the present disclosure; -
FIG. 22P is a flow cytometry diagram depicting FITC-Dextran 10 kDa fluorescence as a function of SSC-A of experimental sample in accordance with aspects of the present disclosure; -
FIG. 23A is a flow cytometry diagram depicting calcein green fluorescence as a function of SSC-A in accordance with aspects of the present disclosure; -
FIG. 23B is a flow cytometry diagram depicting FITC-dextran 10 kDa fluorescence as a function of SSC-A in accordance with aspects of the present disclosure; - FIB. 23C is a flow cytometry diagram depicting FITC-
dextran 70 kDa fluorescence as a function of SSC-A in accordance with aspects of the present disclosure; -
FIG. 23D is a flow cytometry diagram depicting FITC-dextran 150 kDa fluorescence as a function of SSC-A in accordance with aspects of the present disclosure; -
FIG. 23E is a flow cytometry diagram depicting FITC-dextran 500 kDa fluorescence as a function of SSC-A in accordance with aspects of the present disclosure; -
FIG. 23F is a flow cytometry diagram depicting FITC-dextran 2000 kDa fluorescence as a function of SSC-A in accordance with aspects of the present disclosure; -
FIG. 24 schematically depicts a cartridge according to an embodiment, which includes a thermoplasmonic substrate according to the present teachings; -
FIG. 25A is a top schematic view of a device according to an embodiment of the present teachings, which can receive the cartridge shown inFIG. 24 and expose its metalized surface to laser radiation; -
FIG. 25B is a perspective schematic view of the device depicted inFIG. 25A ; -
FIG. 26 schematically depicts the introduction of a sample, e.g., a sample containing cell, into the cartridge depicted inFIG. 24 . - The present disclosure relates generally to substrates for use in processing cells and method of cells processing that allow causing changes in cells that facilitate uptake of cargos by the cells. As discussed in more detail below, in some embodiments, a medium containing one or more cells and one or more cargos to be internalized by the cells is disposed on a substrate surface having a plurality of metalized projections. The application of continuous wave radiation or a plurality of laser pulses to the cells can mediate the uptake of the cargo(s) by the cells. It has been discovered that the use of nanosecond pulses in combination with a substrate having metalized projections as discussed herein leads to efficient introduction of many types of cargos into cells at a high cell viability. In some embodiments, the substrates and the methods of the invention allow for the direct delivery of functional cargo to millions of cells on a minute timescale (e.g., at a rate of at least about 50,000 cells/min). Such a high throughput processing of cells can find applications in a variety of different areas, such as gene therapy, drug discovery, high-throughput screening, and the study of cellular function. As discussed in more detail below, a variety of different cargos can be delivered to cells using the substrates and the methods of the invention. By way of example, cargos having molecular weights in a range of about 0.6 to 2000 KDa can be delivered to cells with a high efficiency (e.g., as high as 95%), a high viability (e.g., 98%). Without being limited to any particular theory, in some embodiments, the application of laser radiation to the substrate can cause heating of the projections, particularly at their tips, which can in turn cause formation of bubbles and/or pressure waves in the medium in which the cells are entrained. In some cases, such bubbles can cause formation of transient pores in the cells' membranes, which can in turn facilitate the uptake of the cargo(s) by the cells.
- Various terms are used herein consistent with their common meanings in the art. The following terms are defined below for clarity.
- The term “polymer” is used herein consistent with its common meaning in the art to refer to a macromolecule formed by the chemical union of five or more repeating chemical units, e.g., by repeating monomers.
- The term “cargo” and “agent” as used herein refer to any compound, molecule, molecular complex, and/or biological organisms, such as plasmid or viruses.
- The term “thermoplasmonic” is used herein to refer to the behavior of metallic structures, such as nano-sized structures, that act as heaters by absorbing light energy and converting that energy into heat.
- The efficiency of uptake of a cargo by a plurality of cells refers to the percentage of cells that contain the cargo after undergoing thermoplasmonic intracellular delivery according to the present teachings.
- The cell viability as used herein refers to the percentage of cells that survive after undergoing thermoplasmonic intracellular delivery according to the present teachings.
- The term “about” as used herein denotes a variation of at most 10% around a numerical value.
- The term “substantially” denotes a deviation of at most 5% relative to a complete state and/or condition.
- The term “nanosecond pulse(s)” refers to radiation pulse(s) having a pulse width in a range of about 1 nanosecond to about 1000 nanoseconds, e.g., in a range of about 1 nanosecond to about 500 nanoseconds.
- With reference to flow chart of
FIG. 1 as well asFIGS. 2 and 3 , in a method of processing cells according to an embodiment of the present teachings, one or more cells can be disposed on a metalized surface 100 a of a cell-processing structure 100 (herein also referred to as a thermoplasmonic or cell-processing substrate) in presence of at least one cargo (herein also referred to as agent), such as a biological agent, and irradiated with one or more laser radiation pulses having a pulse width in a range of about 1 nanosecond to 1000 nanoseconds, e.g., in a range of about 1 nanosecond to about 500 nanoseconds, or in a range of about 20 nanoseconds to about 100 nanoseconds, or in a range of about 10 nanoseconds to about 50 nanoseconds so as to cause a transformation in cell(s) that facilitates the uptake of the agent by the cells. By way of example, the transformation caused by the applied laser pulses can be a transient change in the permeability of the cells' membranes, which allows the passage of the agent into the cells. - More specifically, the cell-
processing substrate 100 includes asupport substrate 102 having atop surface 104 across which aplurality projections 106 in the form of pyramids are distributed. In this embodiment, thepyramids 106 are distributed across the surface of thesubstrate 102 as a regular two-dimensional array. In other embodiments, thepyramids 106 may be randomly distributed across the substrate surface. In some embodiments, the pyramids can have a height (H) in a range of about 0.1 μm to about 20 μm, or a range of about 1 μm to about 10 μm. Further, in some embodiments, pyramidal surfaces can form an angle (α) of about 70.6 degrees relative to one another, as shown schematically inFIG. 4 . In this embodiment, thepyramids 106 have a square base characterized by four equal sides having a size in a range of about 10 nm to about 500 μm, e.g., in a range of about 100 nm to 10 μm or in a range of about 100 μm to 400 μm. In other embodiments, thepyramids 106 can have triangular bases. In some embodiments, the spacing between neighboring pyramids can be, for example, in a range of about 1 nm to about 500 μm. In some embodiments, the surface density of the pyramids (i.e., the number of pyramids per unit area of the substrate surface across which the pyramids are distributed) can be in a range of about 1 million /cm2 to about 100 millions /cm2, e.g., in a range of about 10 millions/ cm2 to about 100 millions/cm2, or in a range of about 20 millions/cm2 to about 100 millions/cm2. - With continued reference to
FIG. 3 , in this embodiment, a thin electricalconductive layer 300, such as a thin metal layer, coats the top surface of the substrate including the exposed pyramidal surfaces. In some embodiments, the thickness of the metal layer can be, for example, in a range of about 1 nm to about 100 nm. A variety of metals can be used to form themetal layer 300. Some suitable examples include gold, silver, and copper. In some embodiments, thecoating 300 can be formed of TiN. Thesubstrate 102 can also be formed of a variety of different materials. In this embodiment, thesubstrate 102 is formed of a polymeric material. Some examples of suitable polymeric materials include, without limitation, polymethyl methacrylate, mercapto-ester, epoxy glue, UV glue, and polydimethylsiloxane. In some other embodiments, thesubstrate 102 can be formed of a semiconductor (e.g., silicon, sapphire, and diamond). In some embodiments, thesubstrate 102 can be formed of glass. In some embodiments, thesubstrate 102 can have a thickness in a range of about 10 nm to about 0.5 cm. - One exemplary method for forming the
substrate 100 using photolithographic techniques is discussed below in the Example section. Briefly, a plurality of metalized cavities having inverse pyramidal shapes can be formed in a semiconductor substrate. And the substrate can be used as a template to form a polymeric substrate having a plurality of metalized pyramidal projections distributed across a surface thereof. - The methods according to the present teachings can be employed to deliver a variety of cargos, including organic, inorganic and/or biological agents to a cell. In many cases, the cell's membrane is normally impermeable to such cargos. Some examples of such cargos include, without limitation, a deoxyribonucleir acid (DNA), a ribonucleic acid (RNA), an mRNA, a plasmid, a ribonuclear protein complex (RNP), a peptide, a protein, a dye, a drug, a therapeutic agent, among others. By way of example, the present substrates and methods can be employed to deliver a Cas9/gRNA RNP system to a cell. In some embodiments, molecules having a molecular weight in a range of about 500 Da to about 2,000,000 Da, e.g., in a range of about 10,000 Da to about 1,000,000 Da, can be delivered to cells using the methods and substrates according to the present teachings.
- The present teachings can be used to deliver cargos to a plurality of different types of cells. Some examples of suitable cells include, without limitation, an epithelial cell, a neuron, a fibroblast, a stem cell (e.g., a skin stem cell), an hematopoietic cell, an immune cell (e.g., a T cell), a blood cell, bacteria, a plant cell, a liver cell, and a pancreatic cell. In some cases, the cells are Mammalian cells.
-
FIG. 5 schematically depicts a system for illuminating cells disposed on a thermoplasmonic substrate according to the present teachings so as to deliver one or more cargos to the cells. Thesystem 500 includes a laser source 501 (e.g., a Nd:Yag laser in this embodiment) that generates a plurality of laser pulses. A variety of laser pulse widths can be employed. For example, the laser pulsewidths can be in a range of about 1 ns to about 1000 ns, e.g., in a range of about 10 ns to about 20 ns. In this embodiment, the laser pulses have a pulse width of about 11 ns. Further, in this embodiment, the laser pulses have a central wavelength of 1064 nm and a repetition rate of 50 Hz. The laser pulses pass through an isolator to prevent their back reflection and subsequently pass through a half-wave plate (HWP) 502 to rotate the plane of polarization of the laser pulses. The laser pulses then pass through apolarizer 504. By rotating the polarizer, the intensity of the pulses can be adjusted. Apelican beam splitter 506 directs a small portion of the energy of the pulses onto anenergy detector 508 for measuring the pulse energies, and allows transmission of the remainder of the laser energy to a lens 512, which loosely focuses the pulses onto a substrate 514, via reflection at themirror 510. The substrate can be seeded with a plurality of cells, typically disposed in a medium that contains one or more agents to be internalized by the cells. The substrate can be positioned on a movable X-Y stage that can be moved in two dimensions, e.g., at an average speed of about 10 mm/second, so as to expose different portions of the substrate on which the cells are disposed to the laser pulses. - In some embodiments, the central wavelength of the laser pulses can range from about 10 nm to about 2000 nm. Furthermore, in some cases, the fluence of the laser pulses at the substrate can be in a range of about 0.01 mJ/cm2 to about 1000 mJ/cm2, e.g., in a range of about 40 mJ/cm2 to about 90 mJ/cm2, or in a range of about 50 mJ/cm2 to about 80 mJ/cm2.
- By way of further illustration,
FIGS. 6A, 6B, and 6C schematically depict that thelaser beam 600 can concurrently illuminate a plurality of pyramids on or in proximity of which cells are disposed. By way of example, the number of concurrently illuminated pyramids can be up to 500 million pyramids, e.g., in a range of about 100 million to about 500 million pyramids. The illumination of the pyramids by the continuous wave or pulsed laser radiation can in turn facilitate the uptake of one or more agents (e.g., molecules) on or in proximity of the pyramids (e.g., at a distance less than hundreds of nanometers (such as 1000 nm) relative to one or more pyramids). In this manner, the method of the present teachings allow parallel processing of a plurality of cells, thus providing an efficient method for delivering cargos to cells. - In some embodiments, the methods of the present teachings can be used to deliver cargos to cells at an efficiency of at least about 40%, e.g., in a range of about 60% to about 90%, and a cell viability of at least about 60%, e.g., in a range of about 60% to about 95%.
- In some embodiments, the electrical
conductive layer 300 has a substantially uniform thickness across the substrate surface. Further, the pyramidal projections can have substantially uniform heights and base lengths. Such uniformity can advantageously allow a consistent processing of cells disposed on different portions of the substrate surface. - In some embodiments, the methods according to the present teachings allow processing cells at a high throughput, e.g., at a throughput in a range of about 1 cell per min to about 500 million cells per minute, e.g., in a range of about 10 million cells per minute to about 500 million cells per minute, or in a range of about 50 million cells per minute to about 500 million cells per minute, or in a range of about 100 million cells per minute to about 500 million cells per minute. Further, the methods discussed herein allow the introduction of cargos into a variety of cells at a high efficiency (e.g., an efficiency greater than about 80%, or greater than about 90%) and with a high cell viability (e.g., a cell viability greater than about 80%, or greater than about 90%). Further, unlike some conventional methods, the use of the methods discussed herein for processing cells does not result in the introduction of cytoxic substances from the substrate (e.g., pieces of the conductive coating) into the processed cells.
- In some aspects, the present invention provides a cartridge comprising a plasmonic substrate according to the present teachings and a device that can receive such a cartridge and illuminate cells disposed on the plasmonic substrate.
- By way of example,
FIG. 24 schematically depicts acartridge 2400 comprising ahousing 2401 in which a cell-processing substrate 2402 according to the present teachings, such as those discussed above, is disposed. As discussed above, the cell-processing substrate 2402 can include asurface 2402a (herein also referred to as a metalized surface) having a plurality of projections that are at least partially coated with an electrically conductive layer. In this embodiment, the cell-processing substrate 2402 is disposed between twopolymeric layers gap 2408 between the metalized surface of the plasmonic substrate, i.e., the surface including the metal-coated pyramids, and thepolymer layer 2406 allows injecting a sample containing cells onto the metalized surface of theplasmonic substrate 2402a via aport 2407 provided in the cartridge housing. The cartridge housing and thepolymeric layers polymeric layers -
FIGS. 25A and 25B schematically depict adevice 2500 that can receive thecartridge 2400 and illuminate a sample disposed on its metalized surface. Thedevice 2500 includes ahousing 2502 in which various components of the device are disposed. More specifically, thedevice 2500 includes alaser head 2504 that contains a laser source, e.g., a diode laser, and the associated electronics for generating a laser beam for the illumination of a sample disposed on the metalized surface of a plasmonic substrate, as discussed in more detail below. Some examples of laser include, without limitation, continuous-wave lasers and pulsed lasers, e.g., lasers generating nanosecond or femtosecond radiation. - The
housing 2502 further includes anenclosure 2506 having aslot 2506a through which thecartridge 2400 can be inserted into the enclosure to be placed in the path of the laser beam generated by thelaser head 2504. In this embodiment, anx-y scanning module 2508 can scan the laser beam over the metalized surface of the plasmonic substrate of the cartridge so as to illuminate different portions thereof, e.g., the portions in contact with the sample containing cells. The x-y scanning module can be implemented in a variety of different ways. By way of example, the scanning module can include two rotatable mirrors that rotate about orthogonal axes. - More specifically, in this embodiment, a
beam splitter 2507 reflects a small portion of the laser beam to anenergy meter 2509 while allowing the rest of the laser beam to pass therethrough to reach thex-y scanning module 2508, which scans the beam over a sample disposed on the metalized surface of the cartridge. - In this embodiment, the
polymeric layer 2406 is selected to be substantially transparent to the laser radiation, thereby allowing efficient illumination of a sample disposed on the metalized surface of the cell-processing substrate via the laser radiation. - The
device 2500 further includes ahardware module 2510 that can include control circuitry and associated electronics for operating and controlling the device, e.g., for controlling the scanning module and the laser. - With reference to
FIG. 26 , in use, a user can introduce, e.g., via a syringe, a sample, e.g., a sample containing cells, onto the metalized surface of the cell-processing substrate contained in the plasmonic cartridge. The cartridge can then be inserted into thedevice 2500 to be exposed to laser radiation. The scanning module can scan the laser radiation over different locations of the metalized surface of the plasmonic substrate so as to expose portions of the sample disposed at those locations to the radiation. - Thermoplasmonic substrates were fabricated using silicon master templates. Specifically, silicon master templates were fabricated using the following methods. A
silicon wafer 700 was sonicated in acetone (5 min) and methanol (5 min) before being rinsed in isopropyl alcohol (IPA) (FIG. 7A ). O2 plasma cleaning of the wafers was then performed (100 W, 20 mT, 1 min). A chromium (Cr) hardlithographic mask 702 was then deposited on the wafer via thermal evaporation (Cr thickness=150 Å). The wafer was baked (200° C., 3 min) to evaporate all solvents before processing. An SPR 700-1photoresist 704 was spin-coated onto the wafer (3000 RPM, 45 s, ramp of 1000 RPM/s). The wafer was then soft baked (115° C., 60 s) (FIG. 7B ). The entire area of the silicon wafer was exposed in an autostepper to form a grid-based pattern. A post-exposure bake was performed (115° C., 60 s). The wafer was then developed in CD-26 developer (1 min), then rinsed with deionized (DI) water (20 s). Development was repeated until no residue was released into the developer. The plasma stripper was then used to descum the wafer (100 W, 20 mT, 15 s) (FIG. 7C ). A chromium etch was performed (12 s, 15 angstroms/s etched, room temperature) to remove the Cr in the exposed squares. The sample was then washed with DI water and dried with an N2 gun. The photoresist was removed in acetone. An O2 plasma clean was performed (100 W, 20 mT, 3 min) to completely remove residual photoresist (FIG. 7D ). An HF etch (4.9% HF) was used to remove oxide formed on the silicon (15 s). A KOH etch (2 parts water and 1 part of 45% KOH), was performed on a hotplate with a thermometer to form a plurality of inverted pyramids in the substrate (80° C., 3 min) (FIG. 7E ). Chromium etching was performed to remove the hard mask (20 s, room temperature) (FIG. 7F ). - The thermoplasmonic substrates were formed in the following way. A
gold layer 706 was deposited via an electron beam evaporator on a silicon master template (gold thickness=50 nm) (FIG. 7G ). A glass coverslip 708 (no. 1.5) was glued to the gold-coated master template with UV curable glue (Norland Adhesive 61) and cured under the UV lamp overnight (FIG. 7H ). A thermoplasmonic substrate was peeled off (“template-strip”) from the template using a razor blade (FIG. 7I ) resulting in a final substrate with about 10 million pyramids (FIG. 7J ). By repeating gold deposition and template-stripping, large quantities of thermoplasmonic substrates were fabricated with high precision. The master template for the fabrication of the thermoplasmonic substrate can be re-used hundreds of times for template-stripping. This approach allows for low-cost, highly-precise, and highly-reproducible fabrication of thermoplasmonic substrates. -
FIG. 8A shows an image of a thermoplasmonic substrate that is comparable in size to a U.S. quarter. -
FIGS. 8B and 8C show, respectively, a scanning electron microscopy (SEM) image of a top view, and an SEM image of a side view, of thermoplasmonic substrates formed using the above process. Characterization through SEM confirms that the pyramids of the template-stripped thermoplasmonic substrates are highly uniform in base lengths (2.4 μm), spacings (1.4 μm), and heights (1.4 μm), and consistent from batch to batch. - Numerical simulations were performed to image the temperature profile of laser-irradiated pyramids (
FIGS. 9A-B ) of thermoplasmonic substrates and to determine the threshold laser fluence required for the temperature at the pyramidal apex of a thermoplasmonic substrate to reach the temperature range necessary to form bubbles within an aqueous environment (FIGS. 9C-E ). - Without being limited to any particular theory, the pyramids of the thermoplasmonic substrates are effective nano-heaters due to the combined effect of their thin metal film, sharp apex, and gold composition, making them ideal for thermoplasmonic applications. Sharp metallic nanostructures are ideal for absorbing laser energy and concentrating the energy to hotspots that heat an aqueous environment and generate bubbles.
- The light-substrate interactions in an aqueous environment was simulated using a Finite Element Method (Comsol, Multiphyiscs 4.4). First, the three-dimensional electromagnetic interaction was calculated using the scattered field formulation under the assumptions that the spot size was large compared to the periodic pyramid structure (plane wave approximation) and that the optical properties of the polymer, gold film and adjacent water did not change during the interaction with the linearly polarized 11 ns (FWHM) Gaussian pulses. The geometrical parameters (pyramid base length: 2.4 μm; spacing: 1.2 μm; and thickness of the gold layer: 50 nm) were chosen to resemble those of the fabricated samples. Periodic boundary conditions in the x and y directions were applied. The simulation domain in the z-direction was truncated using perfectly matched layers (PML). The calculated laser energy absorbed was used as a transient heat source for a one-temperature model. The spatial and temporal evolution of the gold and water temperature was calculated for different laser fluences. More details about the setup of the simulation can be found in Demesy et al., “Tridimensional Multiphysics Model for the Study of Photo-induced Thermal Effects in Arbitrary Nano-structures”, JEOS:RP, 2011, vol. 6, 11037. The physical properties of gold and water were taken from Ekici et al., “Thermal Analysis of Gold Nanorods Heated with Femtosecond Laser Pulses” J. Phys. D Appl. Phys., 2008, 41(18), 185501. Properties of the UV glue were provided by the manufacturer.
-
FIG. 9A shows a perspective view generated by Finite Element Method simulation of a thermoplasmonic substrate according to the present teachings, demonstrating that the thermoplasmonic pyramidal apexes reach a maximum temperature of 342° C. at a laser fluence of 45 mJ/cm2.FIG. 9B shows a top view generated by Finite Element Method simulation of a pyramid from the thermoplasmonic substrate depicting the temperature distribution of the pyramid.FIG. 9C shows a plurality of graphs depicting the temporal evolution of the maximum water temperature near nano-hotspots of a thermoplasmonic substrate for different laser fluences, andFIG. 9D shows a plurality of graphs depicting the temporal evolution of the maximum temperature of water and gold for a laser fluence of 55 mJ/cm2. The envelope of the excitation pulse is indicated in gray in bothFIGS. 9C and 9D .FIG. 9E shows a the maximum water and gold temperature for different laser fluences. - The simulation results show that for fluences above 40 mJ/cm2, the aqueous environment within tens of nanometers surrounding the pyramidal apex reaches temperatures above 300° C., which are within the temperature range for bubble formation. The critical temperature of water at 1 atm is in a range of 367° C. to 377° C., and thermodynamic theory and experimental studies show that explosive boiling occurs where temperatures reach 80-90% of this critical value, which corresponds to temperatures between 293-340° C.
- The laser experiments with cells were performed above the threshold laser fluence necessary for bubble formation (40 mJ/cm2).
- Thermoplasmonic substrates were illuminated at a high fluence and characterized through scanning electron microscopy (SEM) to determine the damage done to the pyramids after laser illumination.
FIG. 10 shows an SEM image of a top view of a thermoplasmonic substrate after laser illumination at a fluence of 200 mJ/cm2 demonstrating the melting of the thin gold film above the pyramid and no visible effect on the polymer layer under the gold film. - The laser experiments with cells were performed below the point where the gold film at the pyramidal apex is damaged (200 mJ/cm2).
- HeLa cells were seeded on thermoplasmonic substrates. HeLa CCL-2 cells were cultured in DMEM (10% FBS, 1% penicillin streptomycin) and incubated (37° C., 5% CO2). Cells were passaged every other day, and used for experiments at 80% confluence, between passage numbers 15-30. Cells were washed with PBS (8 mL) and incubated (3 min) with trypsin (5 mL), before being neutralized with cell media (13 mL). Pipetting was used to wash the bottom of flask 5 times with the cell mixture before transferring the cell mixture to a tube (15 mL) and centrifuging it (5 min, 125 g). The supernatant was removed gently with vacuum pipette and cells were re-suspended in fresh media (8 mL) and pipetted 30 times (up and down counted as 1 time). Countessa cell counter was used to measure cell density and viability. Healthy cells have 90-99% viability. 8 template-stripped substrates were taped lightly to the bottom of a petri dish (100 mm) with double-sided Kaptone tape. 5 million cells were suspended in fresh cell media (15 mL) and added to the petri dish for overnight incubation.
- HeLa cells were chemically fixed on thermoplasmonic substrate. Samples were soaked in fixing solution (1 part 25% glutaraldehyde, 1 part 1M Hepes, 8 parts millipore water) (<10 min). Samples were soaked in buffer solution (2 parts 1M Hepes, 8 parts millipore water) and wrapped with parafilm before overnight storage (5° C.). The following day, the samples were rinsed by soaking in millipore water (<5 min). The samples were then dehydrated with ethanol by soaking them in 50% ethanol (5 min), 70% ethanol (5 min), 90% ethanol (5 min), 100
% ethanol 3 times (<7 min each, total of 20-30 minutes), and 100% ethanol with molecular sieves (grade: 3 Angstrom) (7 min). Samples were finally soaked inHMDS 3 times (≤7 min each, total 20-30 minutes) before air drying at room temperature. - The morphology of HeLa cells on thermoplasmonic substrate was imaged using scanning electron microscopy (SEM) and confocal microscopy techniques.
-
FIG. 11A shows an SEM image of a chemically-fixed cell on pyramids of a thermoplasmonic substrate. Because chemical fixation kills the cell and alters the cell's lipid membranes, confocal microscopy was additionally used to image the morphology of a living cell that was fluorescently tagged with a cell-permeant dye for living cells (FIGS. 11B-D ).FIG. 11B shows a confocal laser-scanning microscopy image of a slice of a cell (40 μm in length) with calcein red-orange AM fluorescence at z=8.85 μm as measured from the bottom of the cell. The confocal slice reveals regular cell morphology.FIG. 11C shows a scan closer to the bottom of the cell at z=3.42 μm that makes pyramids appear in a dark grid-like pattern as the pyramids do not fluoresce in this channel. A z-stack cross section of the cell along the dotted white line fromFIG. 11C is shown inFIG. 11D and depicts the membrane adhering to the pyramids. Both imaging methods indicate that each cell adheres to approximately 40-50 pyramids. - The thermoplasmonic substrates were laser scanned to perform intracellular delivery of cargo. Substrates with Hela cells on the surface were transferred to a petri dish (35 mm) and pre-warmed with PBS solution (2 mL, 37° C.) containing the molecules to be introduced into the cells (Calcein green at 500 μM or FITC-Dextran at 25 mg/mL). The laser setup (
FIG. 5 ) included an Nd:YAG source generating laser pulses at a wavelength of 1064 nm. The pulses were 11 ns in duration, with a repetition rate of 50 Hz. The laser passed through an optical isolator and a half-wave plate (HWP) and polarizer (P) that was controlling the laser energy passing through the setup. The half-wave plate was software-controlled, so the laser energy was changed remotely. A pelican beam splitter sent 8% of the beam to an energy detector (ED) to constantly monitor the energy during an experiment. A lens (L) loosely focused the beam (1.2 mm in diameter) on the sample which sat on an x-y translational stage. - For the fluence experiments (
FIG. 12A-12H ), the laser was scanned in a line across the sample, with each line at a different fluence. Longer distances were scanned to avoid cells being affected by the acceleration and deceleration of the stage (scan speed of 10 mm/s and Δx of 100 mm), which can change the number of pulses hitting the sample and can affect the viability and efficiency of the technique. For flow cytometry experiments (FIGS. 16-19 ) the exact same procedure as the fluence scanning experiments were used and the entire sample was scanned (scan speed: 10 mm/s, Δx: 100 mm, Δy: 0.5 mm, total time˜10 min). The petri dish contained the dye to be delivered in PBS solution. Negative control of areas with pyramids and no laser irradiation, and areas with no pyramids and no irradiation were performed on the same sample for each experiment. - The intracellular delivery of cargo at high efficiency and viability with no damage to the substrate was demonstrated using SEM and fluorescence microscopy techniques.
- Hela Cells were cultured on a thermoplasmonic substrate fabricated as discussed above, put in a solution containing dissolved cargo, laser-scanned, and imaged using fluorescence and dark-field microscopy techniques.
FIG. 12A shows a bright-field image overlaid with a fluorescent image with excitation and emission wavelengths of 495/515 nm, respectively of the cells after laser illumination with dissolved Calcein green molecules. Areas I and III contain gold-coated pyramids, whereas areas II and IV are flat gold. Areas III and IV were laser-scanned, while areas I and II were not. Only area III—the area containing gold-coated pyramids that was irradiated by the laser radiation—demonstrates the successful delivery of cell-impermeable Calcein green molecules to the cells. This observation confirms that gold-coated pyramids in combination with laser-irradiation leads to the delivery of molecules into cells. Furthermore, the pyramidal surface on the left reflects less light than the flat gold on the right, making the surface appear darker. This demonstrates that the technique offers spatially-selective delivery, and works only when cells are cultured on pyramids and laser-scanned. - Automated cell counting was performed on fluorescent images to determine how many cells had cargo delivered to the cytoplasm (efficiency), and how many of those cells were alive after irradiation (viability). Cell counting was done with a Fiji Image processing software using fluorescent images of the samples. The final cell count was checked to make sure that none of the cells was missed, and additional cells were added in the cell counter window. The following definitions were used to calculate viability and efficiency percentages: Viability=NCAM Red/Naverage and Efficiency=Ngreen/Naverage, where NCAMRed is the number of alive cells (in red) in the field of view, Naverage is the average number of alive cells in a not laser-treated area, and NGreen is the number cells that appear green due to delivery of green macromolecules. Cell counting was always performed on a region of the same size across different samples. Triplicate experiments were performed for all data sets.
- The efficiency of cargo delivery to HeLa cells that were cultured on the thermoplasmonic substrate and laser-scanned was determined using Calcein green molecule (
FIG. 12C ). A second dye, Calcein red-orange AM, was used to check the post-experimental viability of the cells (FIG. 12D ). An overlay of the efficiency and viability shows that cells with Calcein green delivered to the cytoplasm survive the experiment (FIG. 12E ). - The experiment was repeated at different laser fluences to determine the optimum laser fluence for maximum delivery efficiency and viability (
FIG. 12B ). Each laser fluence experiment was repeated on 3 separate substrates, in 3 separate dishes, for triplicate (n=3) results. The optimum fluence, where both efficiency (90%) and viability (95%) are maximized, was found to be 54 mJ/cm2. Simulation results previously discussed showed that the local temperature reaches 370° C. at this fluence, which is in the temperature range for bubble formation. - The cells were chemically fixed after laser scanning and an SEM image of the substrate was taken in order to determine if the pyramids experience any damage or melting during laser exposure at the optimum fluence of 54 mJ/cm2 (
FIG. 12F ). No visible damage was observed to individual pyramids in the laser-treated area despite having been exposed to a fluence of 54 mJ/cm2 and despite having undergone intense thermoplasmonic heating at the apex (inset ofFIG. 12H ). Furthermore, no damage was observed on substrate after laser experiment at different fluence scans, such as at 48 mJ/cm2 (FIG. 13A ), 52 mJ/cm2 (FIG. 13B ), 56 mJ/cm2 (FIG. 13C ), and 60 mJ/cm2 (FIG. 13D ). - All consecutive experiments were performed at the optimum fluence of 54 mJ/cm2 because it offers the highest efficiency and viability, and no visible damage.
- The distribution of cargo delivered to the cytoplasm of the cell was demonstrated using fluorescence microscopy. FITC-
dextran 150 kDa was delivered into the cytoplasm of the cells and distributed evenly within each cell (FIG. 14A ) while keeping most of the cells viable (FIG. 14B ). - The proliferation of the cells after thermoplasmonic treatment was demonstrated using fluorescence microscopy. The cells were imaged after 24 hours and 48 hours of FITC-
dextran 150 kDa delivery (FIGS. 15A and 15C ) and Calcein AM delivery (FIGS. 15B and 15D ). The cells showed the retention of FITC-dextran 150 kDa after 48 hours of delivery. The cells also showed an increase in density after 48 hours, indicating that the cells not only remain viable but continue to divide after laser illumination. - The gold content in the cells after laser experiments was measured using inductively coupled plasma mass spectroscopy (ICP-MS). Even though cells may appear viable after undergoing intracellular delivery with this technique, there is a potential risk of DNA mutations if gold nano-fragments remain in the cell.
- Prior to performing ICP-MS analysis, the samples were first weighed out on an analytical balance into clean BD Falcon tubes (15 ml) and then digested using ultrapure hydrochloric_acid overnight. The next day, samples were diluted to a desired volume (usually 5 or 10 ml) with deionized water. A fresh calibration curve was run with the sample. A method blank was run with the batch of samples (this was also used to calculate the detection limit) and calibration verification standards were run to calculate percent recoveries.
-
FIG. 16 shows a table summarizing the results from the ICP-MS analysis fordextran 10 kDa cargo. Cells that undergo thermoplasmonic intracellular delivery had a signal that is representative of background noise, as did cells that were not in contact with gold. ICP-MS measurements on cells that were incubated with gold nanoparticles (and then washed several times to remove floating nanoparticles) exhibited greater gold content than background noise. ICP-MS verifies that no gold residue remains in the cells post-experiment, therefore excluding risks of gold fragment-induced mutagenesis. - Cargos of different cargo sizes were delivered to Hela cells for flow cytometry measurements to quantify the efficiency and viability of the intracellular delivery technique. Flow cytometry measures the scattered forward and side light, and the fluorescence of cells passing through a beam of light. The forward scattering gives information about the size of a cell, while the side scattering provides information about the internal granularity. A range of cargos (Calcein green 0.623 kDa,
Dextran 10 kDa,Dextran 70 kDa,Dextran 150 kDa,Dextran 500 kDa,Dextran 2000 kDa) was delivered to 1 million HeLa cells by laser scanning the entire thermoplasmonic substrate in 3 minutes. Trypsin was used to detach the cells from the substrate for flow cytometry measurements. - After being laser-scanned, each FITC-cargo that was analyzed (
FIG. 17 ) had 6 samples associated with it, including 3 control samples and 3 experimental samples using the conditions shown in the table presented inFIG. 18 . The samples were washed with PBS twice (10 mL and 1 mL). Trypsin (2 mL) was added in a dish (35 mm) and incubated (7 min) before neutralizing with pre-warmed cell media (5 mL). Cells were transferred to a tube (15 mL) and centrifuged (125 g, 5 min). The supernatant was removed and cells were re-suspended in PBS (1 mL) and pipetted up and down 30 times before being transferred to a round bottom test tube (5 mL) with a cell strainer snap cap. Flow cytometry measurements were done using BD LSRFortessaSORP™ cell analyzer running BD FACSDiva software version 6.1.3., using the optical setup that is summarized inFIG. 19 . Measurements were done following the daily instrument QC, which utilized BD CS&T beads (BD Biosciences, catalog no. 642412) in the following order: B0, GOR0, G1, E1-E3. Appropriate gates were set for each sample using flow cytometry analysis software version FCS Express 5 Research Edition (DeNovo Software™; Glendale, Calif.). 10,000 events were recorded for each sample. -
FIGS. 20A-D show flow cytometry diagrams from FITC-Dextran 150 kDa experiments that compare viability and delivery efficiency of sample cells that were not laser-scanned (FIGS. 16A-16B ) and sample cells that were laser-scanned (FIG. 20C-20D ). Both sample cells were initially incubated in a solution containing the cargo to be delivered and then incubated in Calcein AM red-orange for viability indication. For the substrate that was not laser-scanned, the viability is 98.3% and the background signal for delivery is less than 1% (FIG. 20A-20B ). For the laser-scanned substrate, the viability is 98.2% and the delivery efficiency is 74% (FIG. 20C-20D ). -
FIG. 20E shows an histogram of the viability of cells and delivery efficiency of FITC-cargo ranging in size from 0.623 kDa to 2000 kDa. The data represent mean±SE from n=3 independent experiments. The largest cargo, FITC-Dextran 2000 kDa, was delivered with an efficiency of 16%, and a viability of 97% (FIGS. 20E ). The largest increase in efficiency was between FITC-Dextran 500 kDa (24%) and FITC-Dextran 150 kDa (68%). Calcein green (0.623 kDa) was delivered at 95% efficiency and 98% viability. The increased efficiency with decreasing cargo size was attributed to faster diffusion for smaller molecules. The delivered cargos match biologically relevant molecules and functional proteins in molecular weight (13 kDa to 150 kDa). Flow cytometry confirms that this technique offers high throughput, high viability, and high efficiency delivery of different cargo sizes. - The data in
FIG. 20E are normalized by area of pyramids covering the surface. Regular coverslips were 18 by 18 mm, but only 14 by 14 mm of that area was covered in pyramids, the rest was flat gold, where cells do not have cargo delivered to them when scanned with a laser. Therefore flow cytometry experiments for area normalization were performed from FITC-Dextran 150 kDa samples having flat edge (FIG. 21A-D ) and no flat edge (FIG. 21E-H ). In the regular samples (with flat edge), an average efficiency of 48.89% for FITC-Dextran 150 kDa was obtained. A triplicate set of experiments with FITC-150 kDa was done on a sample with no flat gold, only pyramids all across on a 14 by 14 mm area, and an efficiency of 67.67% was obtained. The scaling factor of 1.38 (67.67%/48.89%) was used to normalize the efficiency for the different cargos according to surface coverage of the pyramids. -
FIGS. 22A-P show presentative flow cytometry data for an entire data set for FITC-Dextran 10 kDa experiments including the data from the control blank sample to set the initial gates (FIGS. 22A-D , Sample ID B0), the control sample to determine the background for green dye and the viability of cells without laser scan (FIG. 22E-H , Sample ID G0R0), the negative control sample to determine the viability (FIG. 22 I-L, Sample ID G1), and the experimental samples in triplicate (FIG. 22 M-P, Sample ID E1). -
FIGS. 23A-F show the flow cytometry diagrams for different-sized cargos such as the Calcein green 0.623 kDa (FIG. 23A ), FITC-Dextran 10 kDa (FIG. 23A ), FITC-Dextran 70 kDa (FIG. 23A ), FITC-Dextran 150 kDa (FIG. 23A ), FITC-Dextran 500 kDa (FIG. 23A ), and FITC-Dextran 2000 kDa (FIG. 23A ). - Thermoplasmonic substrates containing plasmonic micron-sized pyramid arrays were again fabricated using photolithography, anisotropic etching of silicon, metal deposition, and template stripping techniques in a manner discussed above. The thermoplasmonic substrate contained pyramidal structures made of glass coverslip, polymer and a 50 nm gold layer, and having a base length of about 2 μm.
- Samples containing HeLa cells and a cargo were seeded on the thermoplasmonic substrates, and the substrates were irradiated with continuous laser radiation using a fiber coupled JDSU diode laser at a wavelength of 980 nm, a power of 500 mW, and an intensity of 104 W/cm2 to deliver the cargo to the cells. More specifically, the samples were positioned in a petri dish and immersed in a solution containing dissolved cargos to be delivered to the cells. The laser beam was focused on the substrate and the petri dish was fixed on an x-y movable stage to scan the sample at a determined speed (which is related to the laser exposure time). The laser parameters were optimized for high-efficiency delivery of small dye molecules like calcein at high-cell viability, using fluorescence microscopy. Alongside small dyes, different-sized fluorescently labeled dextrans were delivered. This method allows for the delivery of molecules in different types of cells. The thermoplasmonic substrate can be reused for repeated high efficiency poration as the substrate undergoes no damage after laser irradiation.
- Small dye fluorescent molecules were delivered into cells using continuous wave laser excitation. Intracellular delivery of calcein green (648 Da) was observed. Cell viability was also demonstrated using calcein AM (magenta), which fluoresces only in living cells where the nonfluorescent calcein AM is converted to a fluorescent calcein after acetoxymethyl ester is hydrolyzed by intracellular esterases.
- Large areas of thermoplasmonic substrates with seeded cells were scanned while changing the laser intensity in order to change the cell metabolism. The change in cell metabolism of HeLa cells was measured using intense continuous wave laser illumination where the efficiency of FITC-
dextran 150 kDa delivery (green) and viability (magenta) was observed for 3 days, i.e.,day 0,day 1, andday 2. The columns were scanned from top to bottom while the laser intensity was increased in discrete steps. Onday 0, the cells exhibited a decrease in enzymatic activity (as shown by observed magenta) as the laser intensity increased. Onday 1, some of the cells recovered. Onday 2, some of the cells underwent cell death. Many cells retained the FITC-Dextran 150 kDa that was delivered to them over several days - Large dye molecules (FITC-Dextran, 150 kDa) were delivered and retained into HeLa cells for 48 hours after continuous wave laser excitation. Long-term retention of larger dye molecules (FITC-Dextran, 150k Da) as well as cell division was observed.
- Those having ordinary skill in the art will appreciate that various changes can be made to the above embodiments without departing from the scope of the invention. The features disclosed in connection with one embodiment can be utilized in another embodiment. Further, a disclosed numerical range is intended to encompass all numerical values within that range.
Claims (22)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/250,714 US10829729B2 (en) | 2016-11-03 | 2019-01-17 | Cellular poration using laser radiation |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662416789P | 2016-11-03 | 2016-11-03 | |
US201662416857P | 2016-11-03 | 2016-11-03 | |
US201762442293P | 2017-01-04 | 2017-01-04 | |
PCT/US2017/059720 WO2018085542A1 (en) | 2016-11-03 | 2017-11-02 | Cellular poration using continuous laser radiation |
PCT/US2017/059743 WO2018085557A1 (en) | 2016-11-03 | 2017-11-02 | Cellular poration using pulsed laser radiation |
US16/250,714 US10829729B2 (en) | 2016-11-03 | 2019-01-17 | Cellular poration using laser radiation |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2017/059743 Continuation-In-Part WO2018085557A1 (en) | 2016-11-03 | 2017-11-02 | Cellular poration using pulsed laser radiation |
Publications (3)
Publication Number | Publication Date |
---|---|
US20190300834A1 US20190300834A1 (en) | 2019-10-03 |
US20200010791A9 true US20200010791A9 (en) | 2020-01-09 |
US10829729B2 US10829729B2 (en) | 2020-11-10 |
Family
ID=68056953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/250,714 Active US10829729B2 (en) | 2016-11-03 | 2019-01-17 | Cellular poration using laser radiation |
Country Status (1)
Country | Link |
---|---|
US (1) | US10829729B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11643667B2 (en) | 2017-08-28 | 2023-05-09 | Cellino Biotech, Inc. | Microfluidic laser-activated intracellular delivery systems and methods |
US20220282201A1 (en) | 2021-03-07 | 2022-09-08 | Cellino Biotech, Inc. | Platforms and systems for automated cell culture |
US11931737B2 (en) | 2021-09-02 | 2024-03-19 | Cellino Biotech, Inc. | Platforms and systems for automated cell culture |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3483934D1 (en) | 1983-10-13 | 1991-02-21 | Rikagaku Kenkyusho | METHOD AND APPARATUS FOR PLANTING A FOREIGN SUBSTANCE INTO LIVING CELL. |
GB8803515D0 (en) | 1988-02-16 | 1988-03-16 | Ici Plc | Method of estimating cumulative exposure to component of gas & apparatus therefor |
US7393924B2 (en) | 2004-01-06 | 2008-07-01 | Franco Vitaliano | Smart bio-nanoparticle elements |
WO2009017695A1 (en) | 2007-07-26 | 2009-02-05 | The Regents Of The University Of California | A single cell surgery tool and a cell transfection device utilizing the photothermal properties of thin films and/or metal nanoparticles |
US8802965B2 (en) | 2008-09-19 | 2014-08-12 | Regents Of The University Of Minnesota | Plasmonic nanocavity devices and methods for enhanced efficiency in organic photovoltaic cells |
EP2272945B1 (en) | 2009-07-06 | 2014-09-10 | Gottfried Wilhelm Leibniz Universität Hannover | Method and system for the manipulation of cells |
KR101968778B1 (en) | 2011-05-13 | 2019-04-12 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | Photothermal substrates for selective transfection of cells |
US9255843B2 (en) | 2011-09-26 | 2016-02-09 | University Of Maryland, College Park | Porous SERS analytical devices and methods of detecting a target analyte |
JP2016519652A (en) * | 2013-03-14 | 2016-07-07 | カリブー・バイオサイエンシーズ・インコーポレイテッド | Nucleic acid targeting nucleic acid compositions and methods |
DE102013108584B3 (en) | 2013-08-08 | 2014-11-06 | Yerzhan Ussembayev | Substrate for the generation of surface plasmons and surface polarites by means of an excitation radiation, method for the production of the substrate and uses of the substrate |
US20180010149A1 (en) | 2015-02-06 | 2018-01-11 | President And Fellows Of Harvard College | Plasmonic nanocavity-based cell therapy method and system |
-
2019
- 2019-01-17 US US16/250,714 patent/US10829729B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20190300834A1 (en) | 2019-10-03 |
US10829729B2 (en) | 2020-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190098559A9 (en) | Optimizations for relay communications | |
US10829729B2 (en) | Cellular poration using laser radiation | |
Flauraud et al. | In-plane plasmonic antenna arrays with surface nanogaps for giant fluorescence enhancement | |
Saklayen et al. | Intracellular delivery using nanosecond-laser excitation of large-area plasmonic substrates | |
Walker et al. | Tailored silicon nanopost arrays for resonant nanophotonic ion production | |
Koh et al. | High-resolution mapping of electron-beam-excited plasmon modes in lithographically defined gold nanostructures | |
Hancu et al. | Multipolar interference for directed light emission | |
Stratakis et al. | Laser-based micro/nanoengineering for biological applications | |
Csaki et al. | A parallel approach for subwavelength molecular surgery using gene-specific positioned metal nanoparticles as laser light antennas | |
Cheng et al. | Surface chemical and mechanical properties of plasma-polymerized N-isopropylacrylamide | |
EP1942179B1 (en) | Chip provided with film having hole pattern with the use of thermoresponsive polymer and method of producing the same | |
Bar et al. | Silicon microchannel-driven Raman scattering enhancement to improve gold nanorod functions as a SERS substrate toward single-molecule detection | |
Courvoisier et al. | Plasmonic tipless pyramid arrays for cell poration | |
US20180010149A1 (en) | Plasmonic nanocavity-based cell therapy method and system | |
WO2018085557A1 (en) | Cellular poration using pulsed laser radiation | |
Wu et al. | Intracellular thermal probing using aggregated fluorescent nanodiamonds | |
Garwe et al. | Optically controlled thermal management on the nanometer length scale | |
Zhang et al. | Multiple plasmonic hot spots platform: Nanogap coupled gold nanoparticles | |
Marcus et al. | Metal nanoparticle deposition for TOF-SIMS signal enhancement of polymers | |
Madrid et al. | Laser-activated self-assembled thermoplasmonic nanocavity substrates for intracellular delivery | |
US11249017B2 (en) | Systems and methods for high frequency nanoscopy | |
Lyu et al. | Double-sided plasmonic metasurface for simultaneous biomolecular separation and SERS detection | |
CN108507991B (en) | Two-photon fluorescence enhancement method and application thereof | |
McGraw et al. | Laser-assisted delivery of molecules in Fungal cells | |
Xie et al. | Optofluidic Accumulation of Silica Beads on Gel-Based Three-Dimensional SERS Substrate To Enhance Sensitivity Using Multiple Photonic Nanojets |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FEPP | Fee payment procedure |
Free format text: PETITION RELATED TO MAINTENANCE FEES GRANTED (ORIGINAL EVENT CODE: PTGR); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 4 |